TANDEM DYES HAVING INTERNALLY POSITIONED SENSORS, AND METHODS FOR MAKING AND USING THE SAME CROSS-REFERENCE TO RELATED APPLICATION Pursuant to 35 U.S.C. § 119 (e), this application claims priority to the filing date of United States Provisional Patent Application Serial No.63/327,960 filed April 6, 2022; the disclosure of which application is incorporated herein by reference in its entirety. INTRODUCTION Fluorescent dyes are compounds which, when irradiated with light of a wavelength which they absorb, emit light of a (usually) different wavelength. Fluorescent dyes find use in a variety of applications in biochemistry, biology and medicine, e.g., in diagnostic kits, in microscopy or in drug screening. Fluorescent dyes are characterized by a number of parameters allowing a user to select a suitable dye depending on the desired purpose. Parameters of interest include the excitation wavelength maximum, the emission wavelength maximum, the Stokes shift, the extinction coefficient, the fluorescence quantum yield and the fluorescence lifetime. Dyes may be selected according to the application of interest in order to, e.g., allow penetration of exciting radiation into biological samples, to minimize background fluorescence and/or to achieve a high signal-to-noise ratio. Molecular recognition involves the specific binding of two molecules. Molecules which have binding specificity for a target biomolecule find use in a variety of research and diagnostic applications, such as the labelling and separation of analytes, flow cytometry, in situ hybridization, enzyme-linked immunosorbent assays (ELISAs), western blot analysis, magnetic cell separations and chromatography. Target biomolecules may be detected by labelling with a fluorescent dye. Some applications, such as flow cytometry applications, employ combinations or panels of differentially fluorescently labeled specific binding members, such as antibodies, for the detection of multiple different targets, e.g., internal or cell surface markers. In such applications, multiple different fluorecent dyes are employed with the same sample, where the multiple different fluorescent dyes are distinguishable from each other in terms of excitation and/or emission maxima. One type of fluorescent dye that finds use in such applications is a tandem fluorescent dye. Tandem fluorescent dyes are compounds having two covalently linked different fluorophores, which fluorophores may be covalently Inked to each other directly or through a linking group. One of the fluorophores serves as donor fluorophore and the other fluorphore acts as acceptor fluorophore. The donor and acceptor fluorophores together form a fluorescenceresonance energy transfer (FRET) pair. Such FRET paisr behave as a unique dye that has the excitation properties of the donor fluorophore and the emission properties of the acceptor fluorophore.

SUMMARY

The inventors have realized that there is a need for more compact tandem dye/sensor conjugates, e.g., dye/antibody pairs, as more compact conjugates are more amendable for intracellular staining. To satisfy this need, the inventors have developed peptidic tandem dyes having internally positioned sensors. These structures allow for biosensing molecules to be bonded directly to sites internal to a peptide scaffold. This configuration has the advantage of allowing for other packing modes upon higher labeling ratios, dye to biosensor, and provides alternative binding modes for a wider range of antibody clones which typically have individual properties and require specific treatments and solutions.

Tandem dyes having internally positioned sensors are provided. Tandem dyes of embodiments of the invention include a peptidic scaffold comprising: one or more donorfluor amino acid residues each conjugated to a pendant donor fluorophore; one or more acceptor-fluor amino acid residues each conjugated to a pendant acceptor fluorophore; and an internal amino acid residue conjugated to a sensor, e.g., a specific binding member, e.g., for a target analyte. In tandem dyes of embodiments of the invention, the donor and acceptor fluorophores of the are in energy transfer relationship. Also provided are methods of making and using the tandem dyes, as well as kits that include the dyes that find use in embodiments of the methods.

DEFINITIONS

As used herein, the terms “chemoselective functional group” and “chemoselective tag” are used interchangeably and refer to a functional group that can selectively react with another compatible functional group to form a covalent bond, in some cases, after optional activation of one of the functional groups. Chemoselective functional groups of interest include, but are not limited to, thiols and maleimide or iodoacetamide, amines and carboxylic acids or active esters thereof, as well as groups that can react with one another via Click chemistry, e.g., azide and alkyne groups (e.g., cyclooctyne groups), tetrazine, transcyclooctene, dienes and dienophiles, and azide, sulfur(VI) fluoride exchange chemistry (SuFEX), sulfonyl fluoride, as well as hydroxyl, hydrazido, hydrazino, aldehyde, ketone, azido, alkyne, phosphine, epoxide, and the like. As used herein, the term “sample” relates to a material or mixture of materials, in some cases in liquid form, containing one or more analytes of interest. In some embodiments, the term as used in its broadest sense, refers to any plant, animal or bacterial material containing cells or producing cellular metabolites, such as, for example, tissue or fluid isolated from an individual (including without limitation plasma, serum, cerebrospinal fluid, lymph, tears, saliva and tissue sections) or from in vitro cell culture constituents, as well as samples from the environment. The term “sample” may also refer to a “biological sample”. As used herein, the term “a biological sample” refers to a whole organism or a subset of its tissues, cells or component parts (e.g., body fluids, including, but not limited to, blood, mucus, lymphatic fluid, synovial fluid, cerebrospinal fluid, saliva, amniotic fluid, amniotic cord blood, urine, vaginal fluid and semen). A “biological sample” can also refer to a homogenate, lysate or extract prepared from a whole organism or a subset of its tissues, cells or component parts, or a fraction or portion thereof, including but not limited to, plasma, serum, spinal fluid, lymph fluid, the external sections of the skin, respiratory, intestinal, and genitourinary tracts, tears, saliva, milk, blood cells, tumors and organs. In certain embodiments, the sample has been removed from an animal or plant. Biological samples may include cells. The term “cells” is used in its conventional sense to refer to the basic structural unit of living organisms, both eukaryotic and prokaryotic, having at least a nucleus and a cell membrane. In certain embodiments, cells include prokaryotic cells, such as from bacteria. In other embodiments, cells include eukaryotic cells, such as cells obtained from biological samples from animals, plants or fungi. The terms “support bound” and “linked to a support” are used interchangeably and refer to a moiety (e.g., a specific binding member) that is linked covalently or non- covalently to a support of interest. Covalent linking may involve the chemical reaction of two compatible functional groups (e.g., two chemoselective functional groups, an electrophile and a nucleophile, etc.) to form a covalent bond between the two moieties of interest (e.g., a support and a specific binding member). In some cases, non-covalent linking may involve specific binding between two moieties of interest (e.g., two affinity moieties such as a hapten and an antibody or a biotin moiety and a streptavidin, etc.). In certain cases, non-covalent linking may involve absorption to a substrate. The term “polypeptide” refers to a polymeric form of amino acids of any length, including peptides that range from 2-50 amino acids in length and polypeptides that are greater than 50 amino acids in length. The terms “polypeptide” and “protein” are used interchangeably herein. The term “polypeptide” includes polymers of coded and non- coded amino acids, chemically or biochemically modified or derivatized amino acids, and polypeptides having modified peptide backbones in which the conventional backbone has been replaced with non-naturally occurring or synthetic backbones. A polypeptide may be of any convenient length, e.g., 2 or more amino acids, such as 4 or more amino acids, 10 or more amino acids, 20 or more amino acids, 50 or more amino acids, 100 or more amino acids, 300 or more amino acids, such as up to 500 or 1000 or more amino acids. “Peptides” may be 2 or more amino acids, such as 4 or more amino acids, 10 or more amino acids, 20 or more amino acids, such as up to 50 amino acids. In some embodiments, peptides are between 5 and 30 amino acids in length. As used herein the term “isolated,” refers to an moiety of interest that is at least 60% free, at least 75% free, at least 90% free, at least 95% free, at least 98% free, and even at least 99% free from other components with which the moiety is associated with prior to purification. A “plurality” contains at least 2 members. In certain cases, a plurality may have 5 or more, such as 6 or more, 7 or more, 8 or more, 9 or more, 10 or more, 20 or more, 30 or more, 40 or more, 50 or more, 60 or more, 70 or more, 80 or more, 90 or more, 100 or more, 300 or more, 1000 or more, 3000 or more, 10,000 or more, 100,000 or more members. Numeric ranges are inclusive of the numbers defining the range. The term "specific binding" refers to a direct association between two molecules, due to, for example, covalent, electrostatic, hydrophobic, and ionic and/or hydrogen- bond interactions, including interactions such as salt bridges and water bridges. A specific binding member describes a member of a pair of molecules which have binding specificity for one another. The members of a specific binding pair may be naturally derived or wholly or partially synthetically produced. One member of the pair of molecules has an area on its surface, or a cavity, which specifically binds to and is therefore complementary to a particular spatial and polar organization of the other member of the pair of molecules. Thus, the members of the pair have the property of binding specifically to each other. Examples of pairs of specific binding members are antigen-antibody, biotin-avidin, hormone-hormone receptor, receptor-ligand, enzyme- substrate. Specific binding members of a binding pair exhibit high affinity and binding specificity for binding with each other. Typically, affinity between the specific binding members of a pair is characterized by a Kd (dissociation constant) of 10 ^-6 M or less, such as 10 ^-7 M or less, including 10 ^-8 M or less, e.g., 10 ^-9 M or less, 10 ^-10 M or less, 10 ^-11 M or less, 10 ^-12 M or less, 10 ^-13 M or less, 10 ^-14 M or less, including 10 ^-15 M or less. "Affinity" refers to the strength of binding, increased binding affinity being correlated with a lower KD. In an embodiment, affinity is determined by surface plasmon resonance (SPR), e.g., as used by Biacore systems. The affinity of one molecule for another molecule is determined by measuring the binding kinetics of the interaction, e.g., at 25 ^o C. "Affinity" refers to the strength of binding, increased binding affinity being correlated with a lower KD. In an embodiment, affinity is determined by surface plasmon resonance (SPR), e.g., as used by Biacore systems. The affinity of one molecule for another molecule is determined by measuring the binding kinetics of the interaction, e.g., at 25 ^o C. Specific binding members may vary, where examples of specific binding members include, but are not limited to, polypeptides, nucleic acids, carbohydrates, lipids, peptoids, etc. In some instances, the specific binding member is proteinaceous. As used herein, the term “proteinaceous” refers to a moiety that is composed of amino acid residues. A proteinaceous moiety can be a polypeptide. In certain cases, the proteinaceous specific binding member is an antibody. In certain embodiments, the proteinaceous specific binding member is an antibody fragment, e.g., a binding fragment of an antibody that specific binds to a polymeric dye. As used herein, the terms “antibody” and “antibody molecule” are used interchangeably and refer to a protein consisting of one or more polypeptides substantially encoded by all or part of the recognized immunoglobulin genes. The recognized immunoglobulin genes, for example in humans, include the kappa (k), lambda (l), and heavy chain genetic loci, which together comprise the myriad variable region genes, and the constant region genes mu (u), delta (d), gamma (g), sigma (e), and alpha (a) which encode the IgM, IgD, IgG, IgE, and IgA isotypes respectively. An immunoglobulin light or heavy chain variable region consists of a “framework” region (FR) interrupted by three hypervariable regions, also called “complementarity determining regions” or “CDRs”. The extent of the framework region and CDRs have been precisely defined (see, “Sequences of Proteins of Immunological Interest,” E. Kabat et al., U.S. Department of Health and Human Services, (1991)). The numbering of all antibody amino acid sequences discussed herein conforms to the Kabat system. The sequences of the framework regions of different light or heavy chains are relatively conserved within a species. The framework region of an antibody, that is the combined framework regions of the constituent light and heavy chains, serves to position and align the CDRs. The CDRs are primarily responsible for binding to an epitope of an antigen. The term antibody is meant to include full length antibodies and may refer to a natural antibody from any organism, an engineered antibody, or an antibody generated recombinantly for experimental, therapeutic, or other purposes as further defined below. Antibody fragments of interest include, but are not limited to, Fab, Fab′, F(ab′) ₂ , Fv, scFv, or other antigen-binding subsequences of antibodies, either produced by the modification of whole antibodies or those synthesized de novo using recombinant DNA technologies. Antibodies may be monoclonal or polyclonal and may have other specific activities on cells (e.g., antagonists, agonists, neutralizing, inhibitory, or stimulatory antibodies). It is understood that the antibodies may have additional conservative amino acid substitutions which have substantially no effect on antigen binding or other antibody functions. In certain embodiments, the specific binding member is a Fab fragment, a F(ab′) ₂ fragment, a scFv, a diabody or a triabody. In certain embodiments, the specific binding member is an antibody. In some cases, the specific binding member is a murine antibody or binding fragment thereof. In certain instances, the specific binding member is a recombinant antibody or binding fragment thereof. In some instances, the specific binding member is a peptoid, e.g., a sequence defined peptoid polymer, such as a supramolecular nanosheet, e.g., as described in Kim et al., "Discovery of Stable and Selective Antibody Mimetics from Combinatorial Libraries of Polyvalent, Loop-Functionalized Peptoid Nanosheets", ACS Nano 2020, 14, 1, 185– 195 (https://doi.org/10.1021/acsnano.9b07498) The methods described herein may include multiple steps. Each step may be performed after a predetermined amount of time has elapsed between steps, as desired. As such, the time between performing each step may be 1 second or more, 10 seconds or more, 30 seconds or more, 60 seconds or more, 5 minutes or more, 10 minutes or more, 60 minutes or more and including 5 hours or more. In certain embodiments, each subsequent step is performed immediately after completion of the previous step. In other embodiments, a step may be performed after an incubation or waiting time after completion of the previous step, e.g., a few minutes to an overnight waiting time. As used herein, the terms “evaluating”, “determining,” “measuring,” and “assessing,” and “assaying” are used interchangeably and include both quantitative and qualitative determinations. The term “separating”, as used herein, refers to physical separation of two elements (e.g., by size or affinity, etc.) as well as degradation of one element, leaving the other intact. The term “linker” or “linkage” refers to a linking moiety that connects two groups and has a backbone of 100 atoms or less in length. A linker or linkage may be a covalent bond that connects two groups or a chain of between 1 and 100 atoms in length, for example a chain of 1, 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 18, 20 or more carbon atoms in length, where the linker may be linear, branched, cyclic or a single atom. In some cases, the linker is a branching linker that refers to a linking moiety that connects three or more groups. In certain cases, one, two, three, four or five or more carbon atoms of a linker backbone may be optionally substituted with a sulfur, nitrogen or oxygen heteroatom. In some cases, the linker backbone includes a linking functional group, such as an ether, thioether, amino, amide, sulfonamide, carbamate, thiocarbamate, urea, thiourea, ester, thioester or imine. The bonds between backbone atoms may be saturated or unsaturated, and in some cases not more than one, two, or three unsaturated bonds are present in a linker backbone. The linker may include one or more substituent groups, for example with an alkyl, aryl or alkenyl group. A linker may include, without limitations, polyethylene glycol; ethers, thioethers, tertiary amines, alkyls, which may be straight or branched, e.g., methyl, ethyl, n-propyl, 1-methylethyl (iso-propyl), n-butyl, n-pentyl, 1,1-dimethylethyl (t-butyl), and the like. The linker backbone may include a cyclic group, for example, an aryl, a heterocycle or a cycloalkyl group, where 2 or more atoms, e.g., 2, 3 or 4 atoms, of the cyclic group are included in the backbone. A linker may be cleavable or non-cleavable. As used herein, the terms “water solubilizing group”, “water soluble group” and WSG are used interchangeably and refer to a group or substituent that is well solvated in aqueous environments e.g., under physiological conditions, and which imparts improved water solubility upon the molecule to which it is attached. A WSG can increase the solubility of a tandem dye or component thereof, e.g., donor or acceptor fluorophore, in a predominantly aqueous solution, as compared to a control tandem dye or component thereof which lacks the WSG. The water solubilizing groups may be any convenient hydrophilic group that is well solvated in aqueous environments. A variety of water soluble polymer groups can be adapted for use in the WSG of the subject dyes. Any convenient water solubilizing groups (WSG’s) may be included in the dyes described herein to provide for increased water-solubility. While the increase in solubility may vary, in some instances the increase (as compared to the compound without the WSG(s)) is 2 fold or more, e.g., 5 fold, 10 fold, 25 fold, 50 fold, 100 fold or more. In some cases, the hydrophilic water solubilizing group is charged, e.g., positively or negatively charged. In certain cases, the hydrophilic water solubilizing group is a neutral hydrophilic group. In some embodiments, the WSG is branched (e.g., as described herein). In certain instances, the WSG is linear. In some embodiments, the WSG is a hydrophilic polymer, e.g., a polyethylene glycol, a modified PEG, a peptide sequence, a peptoid, a carbohydrate, an oxazoline, a polyol, a dendron, a dendritic polyglycerol, a cellulose, a chitosan, or a derivative thereof. Water solubilizing groups of interest include, but are not limited to, carboxylate, phosphonate, phosphate, sulfonate, sulfate, sulfinate, sulfonium, ester, polyethylene glycols (PEG) and modified PEGs, hydroxyl, amine, amino acid, ammonium, guanidinium, pyridinium, polyamine and sulfonium, polyalcohols, straight chain or cyclic saccharides, primary, secondary, tertiary, or quaternary amines and polyamines, phosphonate groups, phosphinate groups, ascorbate groups, glycols, including, polyethers, -COOM′, -SO ₃ M′, -PO ₃ M′, - NR ₃ ⁺ , Y′, (CH ₂ CH ₂ O) _p R and mixtures thereof, where Y′ can be any halogen, sulfate, sulfonate, or oxygen containing anion, p can be 1 to 500, each R can be independently H or an alkyl (such as methyl) and M′ can be a cationic counterion or hydrogen, -- (CH ₂ CH ₂ O) _yy CH ₂ CH ₂ XR ^yy , --(CH ₂ CH ₂ O) _yy CH ₂ CH ₂ X--, --X(CH ₂ CH ₂ O) _yy CH ₂ CH ₂ --, glycol, and polyethylene glycol, wherein yy is selected from 1 to 1000, X is selected from O, S, and NR ^ZZ , and R ^ZZ and R ^YY are independently selected from H and C1-3 alkyl. In some cases, a WSG is (CH ₂ ) _x (OCH ₂ CH ₂ ) _y OCH ₃ where each x is independently an integer from 0-20, each y is independently an integer from 0 to 50. In some cases, the water solubilizing group includes a non-ionic polymer (e.g., a PEG polymer) substituted at the terminal with an ionic group (e.g., a sulfonate). In some embodiments of the formulae, the pendant group of interest includes a substituent selected from (CH ₂ ) _x (OCH ₂ CH ₂ ) _y OCH ₃ where each x is independently an integer from 0-20, each y is independently an integer from 0 to 50; and a benzyl optionally substituted with one or more halogen, hydroxyl, C ₁ -C ₁₂ alkoxy, or (OCH ₂ CH ₂ ) _z OCH ₃ where each z is independently an integer from 0 to 50. In some instances, the substituent is (CH ₂ ) ₃ (OCH ₂ CH ₂ ) ₁₁ OCH ₃ . In some embodiments, one or more of the substituents is a benzyl substituted with at least one WSG groups (e.g., one or two WSG groups) selected from (CH ₂ ) _x (OCH ₂ CH ₂ ) _y OCH ₃ where each x is independently an integer from 0-20 and each y is independently an integer from 0 to 50. Multiple WSGs may be included at a single location in the subject dyes via a branching linker. In certain embodiments, the branching linker is an aralkyl substituent, further di-substituted with water solubilizing groups. As such, in some cases, the branching linker group is a substituent of the dye that connects the dye to two or more water solubilizing groups. In certain embodiments, the branching linker is an amino acid, e.g., a lysine amino acid that is connected to three groups via the amino and carboxylic acid groups. In some cases, the incorporation of multiple WSGs via branching linkers imparts a desirable solubility on the dye. In some instances, the WSG is a non-ionic sidechain group capable of imparting solubility in water in excess of 50 mg/mL. In some instances, the WSG is a non-ionic sidechain group capable of imparting solubility in water in excess of 100 mg/mL. In some embodiments, the dye includes substituent(s) selected from the group consisting of, an alkyl, an aralkyl and a heterocyclic group, each group further substituted with a include water solubilizing groups hydrophilic polymer group, such as a polyethyleneglycol (PEG) (e.g., a PEG group of 6-24 units). Water soluble polymers of interest that can be utilized in the WSG include polyethylene glycol (PEG) groups or modified PEG groups. Water-soluble polymers of interest include, but are not limited to, polyalkylene oxide based polymers, such as polyethylene glycol “PEG” (See. e.g., “Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications”, J. M. Harris, Ed., Plenum Press, New York, N.Y. (1992); and “Poly(ethylene glycol) Chemistry and Biological Applications”, J. M. Harris and S. Zalipsky, Eds., ACS (1997); and International Patent Applications: WO 90/13540, WO 92/00748, WO 92/16555, WO 94/04193,WO 94/14758, WO 94/17039, WO 94/18247, WO 94/28937, WO 95/11924, WO 96/00080, WO 96/23794, WO 98/07713, WO 98/41562, WO 98/48837, WO 99/30727, WO 99/32134, WO 99/33483, WO 99/53951, WO 01/26692, WO 95/13312, WO 96/21469, WO 97/03106, WO 99/45964, and U.S. Pat. Nos.4,179,337; 5,075,046; 5,089,261; 5,100,992; 5,134,192; 5,166,309; 5,171,264; 5,213,891; 5,219,564; 5,275,838; 5,281,698; 5,298,643; 5,312,808; 5,321,095; 5,324,844; 5,349,001; 5,352,756; 5,405,877; 5,455,027; 5,446,090; 5,470,829; 5,478,805; 5,567,422; 5,605,976; 5,612,460; 5,614,549; 5,618,528; 5,672,662; 5,637,749; 5,643,575; 5,650,388; 5,681,567; 5,686,110; 5,730,990; 5,739,208; 5,756,593; 5,808,096; 5,824,778; 5,824,784; 5,840,900; 5,874,500; 5,880,131; 5,900,461; 5,902,588; 5,919,442; 5,919,455; 5,932,462; 5,965,119; 5,965,566; 5,985,263; 5,990,237; 6,011,042; 6,013,283; 6,077,939; 6,113,906; 6,127,355; 6,177,087; 6,180,095; 6,194,580; 6,214,966). Examples of water soluble polymers of interest include, but are not limited to, those containing a polyalkylene oxide, polyamide alkylene oxide, or derivatives thereof, including polyalkylene oxide and polyamide alkylene oxide comprising an ethylene oxide repeat unit of the formula -(CH ₂ -CH ₂ -O)-. Further examples of polymers of interest include a polyamide having a molecular weight greater than 1,000 Daltons of the formula -[C(O)-X-C(O)-NH-Y-NH]n- or -[NH-Y-NH-C(O)-X-C(O)-X-C(O)] _n where X and Y are divalent radicals that may be the same or different and may be branched or linear, and n is a discrete integer from 2-100, such as from 2 to 50, and where either or both of X and Y comprises a biocompatible, substantially non-antigenic water-soluble repeat unit that may be linear or branched. Further examples of water-soluble repeat units comprise an ethylene oxide of the formula -(CH ₂ -CH ₂ -O)- or -(O-CH ₂ -CH ₂ )- . The number of such water-soluble repeat units can vary significantly, with the number of such units being from 2 to 500, 2 to 400, 2 to 300, 2 to 200, 2 to 100, 6-100, for example from 2 to 50 or 6 to 50. An example of an embodiment is one in which one or both of X and Y is selected from: -((CH ₂ ) _n1 -(CH ₂ -CH ₂ -O) _n2 -(CH ₂ )- or -((CH ₂ ) _n1 -(O-CH ₂ -CH ₂ ) _n2 -(CH ₂ ) _n-1 -), where n1 is 1 to 6, 1 to 5, 1 to 4, or 1 to 3, and where n2 is 2 to 50, 2 to 25, 2 to 15, 2 to 10, 2 to 8, or 2 to 5. A further example of an embodiment is one in which X is -(CH ₂ -CH ₂ )-, and where Y is -(CH ₂ -(CH ₂ -CH ₂ -O) ₃ -CH ₂ -CH ₂ -CH ₂ )- or -(CH ₂ -CH ₂ -CH ₂ -(O-CH ₂ -CH ₂ ) ₃ -CH ₂ )-. The term modified polymer, such as a modified PEG, refers to water soluble polymers that have been modified or derivatized at either or both terminals, e.g., to include a terminal substituent (e.g., a terminal alkyl, substituted alkyl, alkoxy or substituted alkoxy, etc.) and/or a terminal linking functional group (e.g., an amino or carboxylic acid group suitable for attachment via amide bond formation) suitable for attached of the polymer to a molecule of interest (e.g., to a light harvesting chromophore via a branching group). The subject water soluble polymers can be adapted to include any convenient linking groups. It is understood that in some cases, the water soluble polymer can include some dispersity with respect to polymer length, depending on the method of preparation and/or purification of the polymeric starting materials. In some instances, the water soluble polymers are monodisperse. The water soluble polymer can include one or more spacers or linkers. Examples of spacers or linkers include linear or branched moieties comprising one or more repeat units employed in a water-soluble polymer, diamino and or diacid units, natural or unnatural amino acids or derivatives thereof, as well as aliphatic moieties, including alkyl, aryl, heteroalkyl, heteroaryl, alkoxy, and the like, which can contain, for example, up to 18 carbon atoms or even an additional polymer chain. The water soluble polymer moiety, or one or more of the spacers or linkers of the polymer moiety when present, may include polymer chains or units that are biostable or biodegradable. For example, polymers with repeat linkages have varying degrees of stability under physiological conditions depending on bond lability. Polymers with such bonds can be categorized by their relative rates of hydrolysis under physiological conditions based on known hydrolysis rates of low molecular weight analogs, e.g., from less stable to more stable, e.g., polyurethanes (-NH-C(O)-O-) > polyorthoesters (-O- C((OR)(R’))-O-) > polyamides (-C(O)-NH-). Similarly, the linkage systems attaching a water-soluble polymer to a target molecule may be biostable or biodegradable, e.g., from less stable to more stable: carbonate (-O-C(O)-O-) > ester (-C(O)-O-) > urethane (-NH- C(O)-O-) > orthoester (-O-C((OR)(R’))-O-) > amide (-C(O)-NH-). In general, it may be desirable to avoid use of a sulfated polysaccharide, depending on the lability of the sulfate group. In addition, it may be less desirable to use polycarbonates and polyesters. These bonds are provided by way of example, and are not intended to limit the types of bonds employable in the polymer chains or linkage systems of the water-soluble polymers useful in the WSGs disclosed herein. The water soluble group (WSG) can be capable of imparting solubility in water in excess of 10 mg/mL to the subject dye or polymeric tandem dye, such as in excess of 20 mg/mL, in excess of 30 mg/mL, in excess of 40 mg/mL, in excess of 50 mg/mL, in excess of 60 mg/mL, in excess of 70 mg/mL, in excess of 80 mg/mL, in excess of 90 mg/mL or in excess of 100 mg/mL. In certain cases, the branched non-ionic water soluble group (WSG) is capable of imparting solubility in water (e.g., an aqueous buffer) of 20 mg/mL or more to the subject dye or polymeric tandem dye, such as 30 mg/mL or more, 40 mg/mL or more, 50 mg/mL or more, 60 mg/mL or more, 70 mg/mL or more, 80 mg/mL or more, 90 mg/mL or more, 100 mg/mL or more, or even more. It is understood that water-soluble dipyrromethene-based dye may, under certain conditions, form discrete water solvated nanoparticles in aqueous systems. In certain cases, the water solvated nanoparticles are resistant to aggregation and find use in a variety of biological assays. The terms “polyethylene oxide”, “PEO”, "polyethylene glycol” and “PEG” are used interchangeably and refer to a polymeric group including a chain described by the formula --(CH ₂ ----O--) _n - or a derivative thereof. In some embodiments, "n" is 5000 or less, such as 1000 or less, 500 or less, 200 or less, 100 or less, 50 or less, 40 or less, 30 or less, 20 or less, 15 or less, such as 3 to 15, or 10 to 15. It is understood that the PEG polymeric group may be of any convenient length and may include a variety of terminal groups and/or further substituent groups, including but not limited to, alkyl, aryl, hydroxyl, amino, acyl, acyloxy, and amido terminal and/or substituent groups. PEG groups that may be adapted for use in the subject multichromophores include those PEGs described by S. Zalipsky in “Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates”, Bioconjugate Chemistry 1995, 6 (2), 150-165; and by Zhu et al in “Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy”, Chem. Rev., 2012, 112 (8), pp 4687–4735. The term “alkyl” by itself or as part of another substituent refers to a saturated branched or straight-chain monovalent hydrocarbon radical derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane. Alkyl groups of interest include, but are not limited to, methyl; ethyl, propyls such as propan-1-yl or propan-2-yl; and butyls such as butan-1-yl, butan-2-yl, 2-methyl-propan-1-yl or 2-methyl-propan-2-yl. In some embodiments, an alkyl group includes from 1 to 20 carbon atoms. In some embodiments, an alkyl group includes from 1 to 10 carbon atoms. In certain embodiments, a lower alkyl group includes from 1 to 6 carbon atoms, such as from 1 to 4 carbon atoms. This term includes, by way of example, linear and branched hydrocarbyl groups such as methyl (CH ₃ -), ethyl (CH ₃ CH ₂ -), n-propyl (CH ₃ CH ₂ CH ₂ -), isopropyl ((CH ₃ ) ₂ CH-), n-butyl (CH ₃ CH ₂ CH ₂ CH ₂ -), isobutyl ((CH ₃ ) ₂ CHCH ₂ -), sec-butyl ((CH ₃ )(CH ₃ CH ₂ )CH-), t-butyl ((CH ₃ ) ₃ C-), n-pentyl (CH ₃ CH ₂ CH ₂ CH ₂ CH ₂ -), and neopentyl ((CH ₃ ) ₃ CCH ₂ -). The term “substituted alkyl” refers to an alkyl group as defined herein wherein one or more carbon atoms in the alkyl chain have been optionally replaced with a heteroatom such as -O-, -N-, -S-, -S(O) _n - (where n is 0 to 2), -NR- (where R is hydrogen or alkyl) and having from 1 to 5 substituents selected from the group consisting of alkoxy, substituted alkoxy, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, acyl, acylamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyaminoacyl, azido, cyano, halogen, hydroxyl, oxo, thioketo, carboxyl, carboxylalkyl, thioaryloxy, thioheteroaryloxy, thioheterocyclooxy, thiol, thioalkoxy, substituted thioalkoxy, aryl, aryloxy, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, hydroxyamino, alkoxyamino, nitro, -SO-alkyl, -SO-aryl, -SO-heteroaryl, -SO ₂ -alkyl, -SO ₂ -aryl, -SO ₂ - heteroaryl, and -NR ^a R ^b , wherein R ^’ and R ^” may be the same or different and are chosen from hydrogen, optionally substituted alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heteroaryl and heterocyclic. “Alkoxy” refers to the group –O-alkyl, wherein alkyl is as defined herein. Alkoxy includes, by way of example, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, t- butoxy, sec-butoxy, n-pentoxy, and the like. The term “alkoxy” also refers to the groups alkenyl-O-, cycloalkyl-O-, cycloalkenyl-O-, and alkynyl-O-, where alkenyl, cycloalkyl, cycloalkenyl, and alkynyl are as defined herein. The term “substituted alkoxy” refers to the groups substituted alkyl-O-, substituted alkenyl-O-, substituted cycloalkyl-O-, substituted cycloalkenyl-O-, and substituted alkynyl-O- where substituted alkyl, substituted alkenyl, substituted cycloalkyl, substituted cycloalkenyl and substituted alkynyl are as defined herein. “Alkenyl" refers to a monoradical, branched or linear, cyclic or non-cyclic hydrocarbonyl group that comprises a carbon-carbon double bond. Exemplary alkenyl groups include ethenyl, n-propenyl, isopropenyl, n-butenyl, isobutenyl, octenyl, decenyl, tetradecenyl, hexadecenyl, eicosenyl, and tetracosenyl. In some cases the alkenyl group comprises 1 to 24 carbon atoms, such as 1 to 18 carbon atoms or 1 to 12 carbon atoms. The term "lower alkenyl" refers to an alkyl groups with 1 to 6 carbon atoms. “Alkynyl” or “alkyne” refers to straight or branched monovalent hydrocarbyl groups having from 2 to 6 carbon atoms and preferably 2 to 3 carbon atoms and having at least 1 and preferably from 1 to 2 sites of triple bond unsaturation. Examples of such alkynyl groups include acetylenyl (-C≡CH), and propargyl (-CH ₂ C≡CH). The term “substituted alkynyl” or “substituted alkyne” refers to an alkynyl group as defined herein having from 1 to 5 substituents, or from 1 to 3 substituents, selected from alkoxy, substituted alkoxy, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, acyl, acylamino, acyloxy, amino, substituted amino, aminoacyl, aminoacyloxy, oxyaminoacyl, azido, cyano, halogen, hydroxyl, oxo, thioketo, carboxyl, carboxylalkyl, thioaryloxy, thioheteroaryloxy, thioheterocyclooxy, thiol, thioalkoxy, substituted thioalkoxy, aryl, aryloxy, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, hydroxyamino, alkoxyamino, nitro, -SO-alkyl, -SO-substituted alkyl, -SO- aryl, -SO-heteroaryl, -SO ₂ -alkyl, -SO ₂ -substituted alkyl, -SO ₂ -aryl, and -SO ₂ -heteroaryl. “Heterocyclyl” refers to a monoradical, cyclic group that contains a heteroatom (e.g. O, S, N) in as a ring atom and that is not aromatic (i.e. distinguishing heterocyclyl groups from heteroaryl groups). Exemplary heterocyclyl groups include piperidinyl, tetrahydrofuranyl, dihydrofuranyl, and thiocanyl. “Amino” refers to the group –NH ₂ . The term “substituted amino” refers to the group -NRR where each R is independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, alkenyl, substituted alkenyl, cycloalkenyl, substituted cycloalkenyl, alkynyl, substituted alkynyl, aryl, heteroaryl, and heterocyclyl provided that at least one R is not hydrogen. "Aryl" by itself or as part of another substituent refers to a monovalent aromatic hydrocarbon radical derived by the removal of one hydrogen atom from a single carbon atom of an aromatic ring system. Aryl groups of interest include, but are not limited to, groups derived from aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene, coronene, fluoranthene, fluorene, hexacene, hexaphene, hexalene, as-indacene, s-indacene, indane, indene, naphthalene, octacene, octaphene, octalene, ovalene, penta-2,4-diene, pentacene, pentalene, pentaphene, perylene, phenalene, phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubicene, triphenylene, trinaphthalene and the like. In certain embodiments, an aryl group includes from 6 to 20 carbon atoms. In certain embodiments, an aryl group includes from 6 to 12 carbon atoms. Examples of an aryl group are phenyl and naphthyl. “Substituted aryl”, unless otherwise constrained by the definition for the aryl substituent, refers to an aryl group substituted with from 1 to 5 substituents, or from 1 to 3 substituents, selected from acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioheteroaryloxy, -SO- alkyl, -SO-substituted alkyl, -SO-aryl, -SO-heteroaryl, -SO ₂ -alkyl, -SO ₂ -substituted alkyl, - SO ₂ -aryl, -SO ₂ -heteroaryl and trihalomethyl. "Heteroaryl" by itself or as part of another substituent, refers to a monovalent heteroaromatic radical derived by the removal of one hydrogen atom from a single atom of a heteroaromatic ring system. Heteroaryl groups of interest include, but are not limited to, groups derived from acridine, arsindole, carbazole, β-carboline, chromane, chromene, cinnoline, furan, imidazole, indazole, indole, indoline, indolizine, isobenzofuran, isochromene, isoindole, isoindoline, isoquinoline, isothiazole, isoxazole, naphthyridine, oxadiazole, oxazole, perimidine, phenanthridine, phenanthroline, phenazine, phthalazine, pteridine, purine, pyran, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, pyrrolizine, quinazoline, quinoline, quinolizine, quinoxaline, tetrazole, thiadiazole, thiazole, triazole, benzotriazole, thiophene, triazole, xanthene, benzodioxole and the like. In certain embodiments, the heteroaryl group is from 5-20 membered heteroaryl. In certain embodiments, the heteroaryl group is from 5-10 membered heteroaryl. In certain embodiments, heteroaryl groups are those derived from thiophene, pyrrole, benzothiophene, benzofuran, indole, pyridine, quinoline, imidazole, oxazole and pyrazine. “Heterocycle,” “heterocyclic,” “heterocycloalkyl,” and “heterocyclyl” refer to a saturated or unsaturated group having a single ring or multiple condensed rings, including fused bridged and spiro ring systems, and having from 3 to 20 ring atoms, including 1 to 10 hetero atoms. These ring atoms are selected from the group consisting of nitrogen, sulfur, or oxygen, wherein, in fused ring systems, one or more of the rings can be cycloalkyl, aryl, or heteroaryl, provided that the point of attachment is through the non-aromatic ring. In certain embodiments, the nitrogen and/or sulfur atom(s) of the heterocyclic group are optionally oxidized to provide for the N-oxide, -S(O)-, or –SO ₂ - moieties. Examples of heterocycles and heteroaryls include, but are not limited to, azetidine, pyrrole, imidazole, pyrazole, pyridine, pyrazine, pyrimidine, pyridazine, indolizine, isoindole, indole, dihydroindole, indazole, purine, quinolizine, isoquinoline, quinoline, phthalazine, naphthylpyridine, quinoxaline, quinazoline, cinnoline, pteridine, carbazole, carboline, phenanthridine, acridine, phenanthroline, isothiazole, phenazine, isoxazole, phenoxazine, phenothiazine, imidazolidine, imidazoline, piperidine, piperazine, indoline, phthalimide, 1,2,3,4-tetrahydroisoquinoline, 4,5,6,7- tetrahydrobenzo[b]thiophene, thiazole, thiazolidine, thiophene, benzo[b]thiophene, morpholinyl, thiomorpholinyl (also referred to as thiamorpholinyl), 1,1- dioxothiomorpholinyl, piperidinyl, pyrrolidine, tetrahydrofuranyl, and the like. “Substituted heteroaryl”, unless otherwise constrained by the definition for the substituent, refers to an heteroaryl group substituted with from 1 to 5 substituents, or from 1 to 3 substituents, selected from acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioheteroaryloxy, -SO- alkyl, -SO-substituted alkyl, -SO-aryl, -SO-heteroaryl, -SO ₂ -alkyl, -SO ₂ -substituted alkyl, - SO ₂ -aryl, -SO ₂ -heteroaryl and trihalomethyl. The term “alkaryl” or “aralkyl” refers to the groups -alkylene-aryl and substituted alkylene-aryl where alkylene, substituted alkylene and aryl are defined herein. “Alkylene” refers to divalent aliphatic hydrocarbyl groups preferably having from 1 to 6 and more preferably 1 to 3 carbon atoms that are either straight-chained or branched, and which are optionally interrupted with one or more groups selected from - O-, -NR ¹⁰ -, -NR ¹⁰ C(O)-, -C(O)NR ¹⁰ - and the like. This term includes, by way of example, methylene (-CH ₂ -), ethylene (-CH ₂ CH ₂ -), n-propylene (-CH ₂ CH ₂ CH ₂ -), iso-propylene (-CH ₂ CH(CH ₃ )-), (-C(CH ₃ ) ₂ CH ₂ CH ₂ -), (-C(CH ₃ ) ₂ CH ₂ C(O)-), (-C(CH ₃ ) ₂ CH ₂ C(O)NH-), (-CH(CH ₃ )CH ₂ -), and the like. “Substituted alkylene” refers to an alkylene group having from 1 to 3 hydrogens replaced with substituents as described for carbons in the definition of “substituted” below. “Substituted” refers to a group in which one or more hydrogen atoms are independently replaced with the same or different substituent(s). Substituents of interest include, but are not limited to, alkylenedioxy (such as methylenedioxy), -M, -R ⁶⁰ , -O-, =O, -OR ⁶⁰ , -SR ⁶⁰ , -S-, =S, -NR ⁶⁰ R ⁶¹ , =NR ⁶⁰ , -CF ₃ , -CN, -OCN, -SCN, -NO, -NO ₂ , =N2, -N3, -S(O) ₂ O-, -S(O) ₂ OH, -S(O) ₂ R ⁶⁰ , -OS(O) ₂ O-, -OS(O) ₂ R ⁶⁰ , -P(O)(O-) ₂ , -P(O)(OR ⁶⁰ ) (O-), -OP(O)(OR ⁶⁰ )(OR ⁶¹ ), -C(O)R ⁶⁰ , -C(S)R ⁶⁰ , -C(O)OR ⁶⁰ , -C(O)NR ⁶⁰ R ⁶¹ ,-C(O)O-, -C(S) OR ⁶⁰ , -NR ⁶² C(O)NR ⁶⁰ R ⁶¹ , -NR ⁶² C(S)NR ⁶⁰ R ⁶¹ , -NR ⁶² C(NR ⁶³ )NR ⁶⁰ R ⁶¹ and -C(NR ⁶² )NR ⁶⁰ R ⁶¹ where M is halogen; R ⁶⁰ , R ⁶¹ , R ⁶² and R ⁶³ are independently hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl, or optionally R ⁶⁰ and R ⁶¹ together with the nitrogen atom to which they are bonded form a cycloheteroalkyl or substituted cycloheteroalkyl ring; and R ⁶⁴ and R ⁶⁵ are independently hydrogen, alkyl, substituted alkyl, aryl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl, or optionally R ⁶⁴ and R ⁶⁵ together with the nitrogen atom to which they are bonded form a cycloheteroalkyl or substituted cycloheteroalkyl ring. In certain embodiments, substituents include -M, -R ⁶⁰ , =O, -OR ⁶⁰ , -SR ⁶⁰ , -S-, =S, -NR ⁶⁰ R ⁶¹ , =NR ⁶⁰ , -CF ₃ , -CN, -OCN, -SCN, -NO, -NO ₂ , =N ₂ , -N ₃ , -S(O) ₂ R ⁶⁰ , -OS(O) ₂ O-, -OS(O) ₂ R ⁶⁰ , -P(O)(O-) ₂ , -P(O)(OR ⁶⁰ )(O-), -OP(O)(OR ⁶⁰ )( OR ⁶¹ ), -C(O)R ⁶⁰ , -C(S)R ⁶⁰ , -C(O)OR ⁶⁰ , -C(O)NR ⁶⁰ R ⁶¹ ,-C(O)O-, -NR ⁶² C(O)NR ⁶⁰ R ⁶¹ . In certain embodiments, substituents include -M, -R ⁶⁰ , =O, -OR ⁶⁰ , -SR ⁶⁰ , -NR ⁶⁰ R ⁶¹ , -CF ₃ , -CN, -NO ₂ , -S(O) ₂ R ⁶⁰ , -P(O)(OR ⁶⁰ )(O-), -OP(O)(OR ⁶⁰ )( OR ⁶¹ ), -C(O)R ⁶⁰ , -C(O)OR ⁶⁰ , -C(O)NR ⁶⁰ R ⁶¹ ,-C(O)O-. In certain embodiments, substituents include -M, -R ⁶⁰ , =O, -OR ⁶⁰ , -SR ⁶⁰ , -NR ⁶⁰ R ⁶¹ , -CF ₃ , -CN, -NO ₂ , -S(O) ₂ R ⁶⁰ , -OP(O)(OR ⁶⁰ )(OR ⁶¹ ), -C(O)R ⁶⁰ , - C(O)OR ⁶⁰ ,-C(O)O-, where R ⁶⁰ , R ⁶¹ and R ⁶² are as defined above. For example, a substituted group may bear a methylenedioxy substituent or one, two, or three substituents selected from a halogen atom, a (1-4C)alkyl group and a (1-4C)alkoxy group. When the group being substituted is an aryl or heteroaryl group, the substituent(s) (e.g., as described herein) may be referred to as “aryl substituent(s)”. It is understood that in all substituted groups defined above, polymers arrived at by defining substituents with further substituents to themselves (e.g., substituted aryl having a substituted aryl group as a substituent which is itself substituted with a substituted aryl group, which is further substituted by a substituted aryl group, etc.) are not intended for inclusion herein. In such cases, the maximum number of such substitutions is three. For example, serial substitutions of substituted aryl groups specifically contemplated herein are limited to substituted aryl-(substituted aryl)- substituted aryl. “Acyl” refers to a group of formula -C(O)R wherein R is alkyl, alkenyl, or alkynyl. For example, the acetyl group has formula -C(O)CH ₃ . “Halo” and “halogen” refer to the chloro, bromo, fluoro, and iodo groups. “Carboxyl”, “carboxy”, and “carboxylate” refer to the -CO ₂ H group and salts thereof. “Sulfonyl” refers to the group -SO ₂ R, wherein R is alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocyclyl, and substituted versions thereof. Exemplary sulfonyl groups includes -SO ₂ CH ₃ and -SO ₂ (C ₆ H ₅ ). Unless otherwise specified, reference to an atom is meant to include all isotopes of that atom. For example, reference to H is meant to include ¹ H, ² H (i.e., D) and ³ H (i.e., T), and reference to C is meant to include ¹² C and all isotopes of carbon (such as ¹³ C). In addition, any groups described include all stereoisomers of that group. Unless indicated otherwise, the nomenclature of substituents that are not explicitly defined herein are arrived at by naming the terminal portion of the functionality followed by the adjacent functionality toward the point of attachment. For example, the substituent “arylalkyloxycarbonyl” refers to the group (aryl)-(alkyl)-O-C(O)-. As to any of the groups disclosed herein which contain one or more substituents, it is understood, of course, that such groups do not contain any substitution or substitution patterns which are sterically impractical and/or synthetically non-feasible. In addition, the subject compounds include all stereochemical isomers arising from the substitution of these compounds. DETAILED DESCRIPTION Tandem dyes having internally positioned sensors are provided. Tandem dyes of embodiments of the invention include a peptidic scaffold comprising: one or more donor- fluor amino acid residues each conjugated to a pendant donor fluorophore; one or more acceptor-fluor amino acid residues each conjugated to a pendant acceptor fluorophore; and an internal amino acid residue conjugated to a sensor, e.g., a specific binding member, e.g., for a target analyte. In tandem dyes of embodiments of the invention, the donor and acceptor fluorophores of the are in energy transfer relationship. Also provided are methods of making and using the tandem dyes, as well as kits that include the dyes that find use in embodiments of the methods. Before describing exemplary embodiments in greater detail, the following definitions are set forth to illustrate and define the meaning and scope of the terms used in the description. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Still, certain terms are defined below for the sake of clarity and ease of reference. Further, although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present invention, representative illustrative methods and materials are described herein. Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges and are also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention. Certain ranges are presented herein with numerical values being preceded by the term "about." The term "about" is used herein to provide literal support for the exact number that it precedes, as well as a number that is near to or approximately the number that the term precedes. In determining whether a number is near to or approximately a specifically recited number, the near or approximating unrecited number may be a number which, in the context in which it is presented, provides the substantial equivalent of the specifically recited number. All publications and patents cited in this specification are herein incorporated by reference as if each individual publication or patent were specifically and individually indicated to be incorporated by reference and are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited. The citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed. It is noted that, as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present invention. Any recited method can be carried out in the order of events recited or in any other order which is logically possible. While the apparatus and method has or will be described for the sake of grammatical fluidity with functional explanations, it is to be expressly understood that the claims, unless expressly formulated under 35 U.S.C. §112, are not to be construed as necessarily limited in any way by the construction of "means" or "steps" limitations, but are to be accorded the full scope of the meaning and equivalents of the definition provided by the claims under the judicial doctrine of equivalents, and in the case where the claims are expressly formulated under 35 U.S.C. §112 are to be accorded full statutory equivalents under 35 U.S.C. §112. In further describing various embodiments of the invention, tandem dyes are reviewed first in greater detail, followed by a review of methods of using and making the dyes, as well as a review of kits that include the conjugates. TANDEM DYES As summarized above, the present disclosure provides tandem dyes having internally positioned sensors. Tandem dyes are dyes having two different types of fluorophores, one type of which functions as a donor and the ther functions as an acceptor, e.g., as described in greater detail below. By internally positioned sensor is meant that a pendant sensor entity, e.g., a specific binding member, e.g., for a target analyte, is bound to an internal repeat unit of a peptidic scaffold of the tandem dye, such that the sensor is bound to an internal amino acid residue of the peptidic scaffold. As such, the sensor is not bound to a terminal repeat unit of the peptidic scaffold, such that it is not present at either end of the peptidic scaffold. Instead, the sensor is covalently bound to an internal residue of the peptidic scaffold, where in some instances the internal residue is one or more, such as two or more, such as three or more, including four or more, e.g., five or more, 10 or more, etc., residues from a given end of the peptidic scaffold. As summarized above, tandem dyes of embodiments of the invention include a peptidic scaffold comprising: one or more donor-fluor amino acid residues each conjugated to a pendant donor fluorophore; one or more acceptor-fluor amino acid residues each conjugated to a pendant acceptor fluorophore; and an internal amino acid residue conjugated to a pendant molecular entity, e.g., which may function as a sensor, e.g., for a target analyte. Each of these components of the violet excitable dyes is now reviewed in greater detail. Peptidic Scaffold As summarized above, tandem fluorescent dyes of embodiments of the invention include a peptidic scaffold. In some instances, the peptidic scaffold is made up of amino acid repeat units having any convenient configuration, such as a linear, branched or dendrimer configuration. The peptidic scaffold can be a linear polymer. In some instances, the tandem dye includes a plurality of pendant donor chromophore groups each independently linked to an amino acid repeat unit of the polymeric backbone. The configuration of pendant groups can be installed during or after synthesis of the peptidic scaffold. The incorporation of pendant groups can be achieved with a random configuration, a block configuration, or in a sequence-specific manner via stepwise synthesis, depending on the particular method of synthesis utilized. The term “unit” refers to a structural subunit of a polymer. The term unit is meant to include monomers, co-monomers, co-blocks, repeating units, and the like. A “repeating unit” or “repeat unit” is a subunit of a polymer that is defined by the minimum number of distinct structural features that are required for the unit to be considered monomeric, such that when the unit is repeated n times, the resulting structure describes the polymer or a block thereof. In some cases, the polymer may include two or more different repeating units, e.g., when the polymer is a multiblock polymer, a random arrangement of units or a defined sequence, each block may define a distinct repeating unit. It is understood that a variety of arrangements of repeating units or blocks are possible and that in the depicted formula of the polymer backbones described herein any convenient linear arrangements of various lengths can be included within the structure of the overall polymer. It is understood that the polymer may also be represented by a formula in terms of mol% values of each unit in the polymer and that such formula may represent a variety of arrangements of repeat unit, such as random or multiblock polymer or a defined sequence of residues. In some cases, a repeating unit of the polymer includes a single monomer group. In certain instances, a repeating unit of the polymer includes two or more monomer groups, i.e., co-monomer groups, such as two, three, four or more co-monomer groups. The term “co-monomer” or “co-monomer group” refers to a structural unit of a polymer that may itself be part of a repeating unit of the polymer. The peptidic scaffold (i.e., backbone) of the tandem dye may have any convenient length. In some cases, the particular number of monomeric repeating units or segments of the backbone may fall within the range of 2 to 500,000, such as 2 to 100,000, 2 to 30,000, 2 to 10,000, 2 to 3,000 or 2 to 1,000 units or segments, or such as 5 to 100,000, 10 to 100,000, 100 to 100,000, 200 to 100,000, or 500 to 50,000 units or segments. In some instances, the particular number of monomeric repeating units or segments of the backbone may fall within the range of 2 to 1,000, such as 2 to 500, 2 to 100, 3 to 100, 4 to 100, 5 to 100, 6 to 100, 7 to 100, 8 to 100, 9 to 100 or 10 to 100 units or segments. In certain cases, the particular number of monomeric repeating units or segments of the backbone may fall within the range of 2 to 500, such as 2 to 400, 2 to 300, 2 to 200, or 2 to 100 units or segments. In certain cases, the particular number of monomeric repeating units or segments of the backone may fall within the range of 2 to 100 repeating monomeric units, such as 2 to 90, 2 to 80, 2 to 70, 2 to 60, 2 to 50, 2 to 40, or 2 to 30 units or segments. The molecular weight of the peptidic scaffold may also vary. In some instances, the molecular weight is 750 to 1,250 g/mol, such as 1,000 g/mol per repeat unit, ranging in some instances from 2,000 to 200,000 g/mol, such as 5,000 to 100,000 g/mol. The peptidic scaffold may have a random configuration of non-conjugated amino acid repeat units. The peptidic scaffold or backbone may include a block or co-block configuration of non-conjugated repeat units. Alternatively, the backbone may include a particular defined sequence of non-conjugated repeat units, e.g., amino acid residues of a polypeptide sequence. These configurations can be characterized by polymeric segments of repeat units (e.g., as described herein), which segments can themselves be repeated throughout the modular scaffold. By “non-conjugated” is meant that at least a portion of the repeat unit includes a saturated backbone group (e.g., a group having two or more consecutive single covalent bonds) which precludes pi conjugation or an extended delocalized electronic structure along the polymeric backbone from one repeat unit to the next. It is understood that even though one repeat unit may not be conjugated to an adjacent repeat unit, such a repeat unit may include one or more isolated unsaturated groups including an unsaturated bond (e.g., of an alkenylene group or an alkynylene group) and/or an aryl or heteroaryl group, which groups can be a part of the backbone. In some cases, each repeat unit of the polymeric backbone includes one sidechain including a linked pendant group or a chemo-selective tag for linking to a pendant group. In certain instances, the tandem dye includes a linear peptide backbone of from 2 to 100 amino acids, such as 2 to 90, 2 to 80, 2 to 70, 2 to 60, 2 to 50, 2 to 40 or 2 to 30 amino acids. In some cases, the linear peptide backbone includes 2 or more amino acids, such as 5 or more, 10 or more, 15 or more, 20 or more, 25 or more, 30 or more, up to a maximum of 100 amino acids. In certain cases, the tandem dye includes a linear peptide backbone of from 5 to 30 amino acids, such as 5 to 25, 5 to 20, 5 to 15, or 5 to 10 amino acids. Where desired, the peptidic scaffold may include one or more non-amino acid spacer residues. Examples of non-amino acid spacers of interest include, but are not limited to, those containing a polyalkylene oxide, polyamide alkylene oxide, or derivatives thereof, including polyalkylene oxide and polyamide alkylene oxide comprising an ethylene oxide repeat unit of the formula -(CH ₂ -CH ₂ -O)-. Further examples of polymers of interest include a polyamide having a molecular weight greater than 1,000 Daltons of the formula -[C(O)-X-C(O)-NH-Y-NH]n- or -[NH-Y-NH-C(O)-X- C(O)] _n -, where X and Y are divalent radicals that may be the same or different and may be branched or linear, and n is a discrete integer from 2-100, such as from 2 to 50, and where either or both of X and Y comprises a biocompatible, substantially non-antigenic repeat unit that may be linear or branched. Further examples of repeat units comprise an ethylene oxide of the formula -(CH ₂ -CH ₂ -O)- or -(O-CH ₂ -CH ₂ )- . The number of such spacer repeat units can vary significantly, with the number of such units being from 2 to 500, 2 to 400, 2 to 300, 2 to 200, 2 to 100, 6-100, for example from 2 to 50 or 6 to 50. In some instances, the spacer is a polyethylene glycol. The terms “polyethylene oxide”, “PEO”, "polyethylene glycol” and “PEG” are used interchangeably and refer to a polymeric group including a chain described by the formula --(CH ₂ ----O--) _n - or a derivative thereof. In some embodiments, "n" is 5000 or less, such as 1000 or less, 500 or less, 200 or less, 100 or less, 50 or less, 40 or less, 30 or less, 20 or less, 15 or less, such as 3 to 15, or 10 to 15. It is understood that the PEG polymeric group may be of any convenient length and may include a variety of terminal groups and/or further substituent groups, including but not limited to, alkyl, aryl, hydroxyl, amino, acyl, acyloxy, and amido terminal and/or substituent groups. PEG groups that may be adapted for use in the subject multichromophores include those PEGs described by S. Zalipsky in “Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates”, Bioconjugate Chemistry 1995, 6 (2), 150-165; and by Zhu et al in “Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy”, Chem. Rev., 2012, 112 (8), pp 4687–4735. When present, the non-amino acid spacer residue(s) may be any convenient location, e.g., at a terminal location, at an internal location, e.g., between two amino acid residues (such that it separates two amino acid residues of the peptidic scaffold), and combinations thereof, etc. Where desired, the peptidic scaffolds present in tandem dyes of embodiments of the invention may be substituted with one or more water solubilizing groups (WSG), e.g., as defined above. Donor Fluorophores As summarized above, tandem dyes of the invention include one or more donor fluorophore (i.e., donor-fluor) amino acid residues each conjugated to a pendant donor fluorophore. The excitation maximum of donor fluorophores found in embodiments of the invention may vary, where in some instances donor fluorophores have an excitation maximum ranging from 340 to 700 nm. Any convenient pendant donor fluorophore may be linked to the amino acid residues of the peptidic scaffold, where donor fluorophores of interest include, but are not limited to: BODIPY fluorphores; aryl fluorphores, heteroaryl fluorophores, and the like. In some some instances, the donor fluorophore is a BODIPY fluorophore. The term “BODIPY fluorophore” refers to a pendant donor fluorphore of a tandem dye which includes a chromophore having the following boron-dipyrromethene (BODIPY) core structure: where Q is C or N and each R is any convenient boron substituent. In some cases, Q is C. In some instances, each R is independently selected from F, OH, H, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkoxy, substituted alkoxy, alkynyl and substituted alkynyl. The BODIPY chromophore groups may be optionally further substituted, e.g., with a water solubilizing group and/or an aryl or heteroaryl substituent that imparts desirable light absorbing properties to the chromophore. Further description of BODIPY fluorophores that may be employed as donor fluorophores in embodiments of the invention are described in PCT application serial no. PCT/US2019/024662 published as WO 2019/191482; the disclosure of which is herein incorporated by reference. In some embodiments, donor fluorophores are fluorophores that include a aryl or heteroaryl chromophore group. Aryl or heteroaryl chromophore groups of interest which find use in embodiments of the invention include, but are not limited to, phenyl, biphenyl, benzooxazole, benzothiazole, poly-phenylene, and fused tricyclic groups, such as fluorene, carbazole, silole, biphenyl and bridged biphenyl. The aryl or heteroaryl chromophore groups may be optionally further substituted, e.g., with a water solubilizing group and/or an aryl or heteroaryl substituent that imparts desirable light absorbing properties to the aryl or heteraryl group. In some embodiments, donor fluorophores include a fused tricyclic aryl or heteroaryl. In some embodiments, donor fluorophores include one or more groups selected from fluorene, carbazole, silole, biphenyl and bridged biphenyl. A fused tricyclic chromophore is a group including a tricyclic aromatic group having three fused rings in a configuration where two aryl or heteroaryl 6-membered rings are fused to a central 5 or 6-membered carbocyclic or heterocyclic ring. In some cases, the fused tricyclic group includes two benzo or pyrido rings fused to a central 5 or 6 membered carbocyclic or heterocyclic ring. The fused tricyclic group can be linked to the sidechain of a co-monomer in the polymeric backbone via any convenient ring atoms of the fused rings. The central 5- or 6- membered ring may be a carbocycle or a heterocycle, aromatic or partially saturated, and may further include a sidechain substituent, e.g., a WSG and/or a linker to a chemoselective tag or the co-monomer sidechain. A bridged biphenyl co-monomer is a fused tricyclic group having a biphenyl group where the two phenyl rings are further linked with each other via a central 6 membered carbocyclic or heterocyclic ring. Further description of aryl/heteroaryl fluorophores that may be employed as donor fluorophores in embodiments of the invention are described in PCT application serial no. PCT/US2019/024662 published as WO 2019/191482; the disclosure of which is herein incorporated by reference. Acceptor Fluorophores As summarized above, tandem dyes of the invention include one or more acceptor fluorophore (i.e., acceptor-fluor) amino acid residues each conjugated to a pendant acceptor fluorophore. In some instances, the tandem dyes include a single acceptor fluorphore and therefore a single acceptor-fluor amino acid residue. In other intstances, the tandem dyes include two or more acceptor fluorphores and therefore two or more acceptor-fluor residues. Any convenient fluorescent dye may be utilized in the polymeric tandem dyes as an acceptor fluorophore. The excitation maximum of acceptor fluorophores found in embodiments of the invention may vary, where in some instances acceptor fluorophores have an excitation maximum ranging from _450___ to _900__nm. The acceptor fluorophore (e.g., each A) can be a small molecule fluorophore. The acceptor fluorophore (e.g., each A) can be a dye molecule selected from a rhodamine, a perylene, a diimide, a coumarin, a xanthene, a cyanine, a polymethine, a pyrene, a thiazine, an acridine, a boron dipyrromethene, a napthalimide, a phycobiliprotein, a peridinum chlorophyll protein, conjugates thereof, and combinations thereof. In certain embodiments, the acceptor fluorophore (A) is a cyanine dye, a xanthene dye, a coumarin dye, a thiazine dye or an acridine dye. In some instances, the acceptor fluorophore (A) is selected from DY 431, DY 485XL, DY 500XL, DY 610, DY 640, DY 654, DY 682, DY 700, DY 701, DY 704, DY 730, DY 731, DY 732, DY 734, DY 752, DY 778, DY 782, DY 800, DY 831, Biotium CF 555, Cy 3.5 and diethylamino coumarin. Fluorescent dyes of interest include, but are not limited to, fluorescein, 6-FAM, rhodamine, Texas Red, tetramethylrhodamine, carboxyrhodamine, carboxyrhodamine 6G, carboxyrhodol, carboxyrhodamine 110, Cascade Blue, Cascade Yellow, coumarin, Cy2, Cy3, Cy3.5, Cy5, Cy5.5, Cy-Chrome, phycoerythrin, PerCP (peridinin chlorophyll-a Protein), PerCP-Cy5.5, JOE (6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein), NED, ROX (5-(and-6)-carboxy-X-rhodamine), HEX, Lucifer Yellow, Marina Blue, Oregon Green 488, Oregon Green 500, Oregon Green 514, Alexa Fluor 350, Alexa Fluor 430, Alexa Fluor 488, Alexa Fluor 532, Alexa Fluor 546, Alexa Fluor 568, Alexa Fluor 594, Alexa Fluor 633, Alexa Fluor 647, Alexa Fluor 660, Alexa Fluor 680, Alexa Fluor 700, 7- amino-4-methylcoumarin-3-acetic acid, BODIPY FL, BODIPY FL-Br.sub.2, BODIPY 530/550, BODIPY 558/568, BODIPY 564/570, BODIPY 576/589, BODIPY 581/591, BODIPY 630/650, BODIPY 650/665, BODIPY R6G, BODIPY TMR, BODIPY TR, conjugates thereof, and combinations thereof. Lanthanide chelates of interest include, but are not limited to, europium chelates, terbium chelates and samarium chelates. In some embodiments, the polymeric tandem dye includes a multichromophore linked to an acceptor fluorophore selected from Cy3, Cy3.5, Cy5, Cy5.5, Cy7, Alexa488, Alexa 647 and Alexa700. In certain embodiments, the polymeric tandem dye includes a multichromophore linked to an acceptor fluorophore selected from Dyomics dyes (such as DY 431, DY 485XL, DY 500XL, DY 530, DY 610, DY 633, DY 640, DY 651, DY 654, DY 682, DY 700, DY 701, DY 704, DY 730, DY 731, DY 732, DY 734, DY 752, DY 754, DY 778, DY 782, DY 800 or DY 831), Biotium CF 555, Cy 3.5, and diethylamino coumarin. In certain cases, the acceptor fluorophore (A) is selected from fluorescein, 6- FAM, rhodamine, Texas Red, California Red, iFluor594, tetramethylrhodamine, a carboxyrhodamine, carboxyrhodamine 6G, carboxyrhodol, carboxyrhodamine 110, Cascade Blue, Cascade Yellow, coumarin, Cy2®, Cy3®, Cy3.5®, Cy5®, Cy5.5®, Cy7®, Cy-Chrome, DyLight 350, DyLight 405, DyLight 488, DyLight 549, DyLight 594, DyLight 633, DyLight 649, DyLight 680, DyLight 750, DyLight 800, phycoerythrin, PerCP (peridinin chlorophyll-a Protein), PerCP-Cy5.5, JOE (6-carboxy-4′,5′-dichloro-2′,7′- dimelhoxyfluorescein), NED, ROX (5-(and -6)-carboxy-X-rhodamine), HEX, Lucifer Yellow, Marina Blue, Oregon Green 488, Oregon Green 500, Oregon Green 514, Alexa Fluor® 350, Alexa Fluor® 430, Alexa Fluor® 488, Alexa Fluor® 532, Alexa Fluor® 546, Alexa Fluor® 568, Alexa Fluor® 594, Alexa Fluor® 633, Alexa Fluor® 647, Alexa Fluor® 660, Alexa Fluor® 680, 7-amino-4-methylcoumarin-3-acetic acid, BODIPY® FL, BODIPY® FL-Br2, BODIPY® 530/550, BODIPY® 558/568, BODIPY® 564/570, BODIPY® 576/589, BODIPY® 581/591, BODIPY® 630/650, BODIPY® 650/665, BODIPY® R6G, BODIPY® TMR, BODIPY® TR, conjugates thereof and combinations thereof. Where desired, the acceptor fluorophores present in tandem dyes of embodiments of the invention may be substituted with one or more water solubilizing groups (WSG), e.g., as defined above. Internally Positioned Sensor As summarized above, the present disclosure provides tandem dyes having internally positioned sensors. By internally positioned sensor is meant that a pendant sensor entity, e.g., specific binding member, e.g., for a target analyte, is bound to an internal repeat unit of a peptidic scaffold of the tandem dye, e.g., such that the tandem dye includes an internal amino acid residue conjugated to a pendant sensor. As such, the sensor is not bound to a terminal repeat unit of the peptidic scaffold, such that it is not present at either end of the peptidic scaffold. Instead, the sensor is covalently bound to an internal amino acid residue of the peptidic scaffold, where in some instances the internal residue is two or more, such as three or more, including four or more, e.g., five or more, 10 or more, etc., residues from a given end of the peptidic scaffold. Furthermore, the sensor in embodiments of the invention may be positioned internal to flanking fluorophores, such that donor and/or acceptor fluorophores are positioned on either side of the internal amino acid residue to which the sensor is covalently bound. In some embodiments, the sensor is flanked on both sides by one or more donor fluorophores, and in some instances is flanked on both sides by a single or plurality of donor fluorophores, e.g., 1 to 25 donor fluorophores, such as 2 to 20 donor fluorophores, such as 5 to 10 donor fluorphores, positioned on either side of the sensor. The internally positioned sensor may be any desired molecular entity, where in some instances the sensor is a a specific binding member that specifically binds to the target analyte. Specific binding members may vary as desired and include those defined above. Additional Aspects of Tandem Dyes Having Internally Positioned Sensors Tandem dyes of embodiments of the invention may vary. In some instances, tandem dyes of embodiments of the invention include: a peptidic scaffold; a plurality of pendant donor fluorophores each independently linked to an amino acid repeat unit of the peptidic scaffold; and one or more pendant acceptor fluorophores linked to an amino acid repeat unit of the peptidic scaffold, where pendant donor and acceptor fluorophores are in energy transfer relationship. As such, tandem dyes of embodiments of the invention include one or more pendant donor fluorophores and one or more pendant acceptor fluorophores, configured in energy-receiving proximity to the one or more pendant donor fluorophores, e.g., where both are linked to a common peptidic scaffold via an amino acid residue thereof. In some embodiments, a plurality of pendant donor fluorophores are present and are configured in energy-transferring proximity to a pendant acceptor fluorophore(s), where in some instances the plurality of pendant donor fluorophores ranges from 2 to 20, such as 2 to 15, e.g., 2 to 10. The term "pendant group" refers to a sidechain group that is connected to the scaffold (i.e., backbone) but which is not part of the backbone itself. Sidechain groups may be any convenient linker group, e.g., as described above. In some embodiments side chain groups are sidechains of naturally occurring or synthetic amin acid side chains. As such, side chains may be those found in the 20 amino acids that make up naturally occuring polypeptides, i.e., alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine. In embodiments of the tandem dyes, the donor fluorophore is capable of transferring energy to a linked acceptor fluorophore. As such, the subject tandem dyes include a linked acceptor signaling fluorophore in energy- receiving proximity to the donor fluorophore system, i.e., in energy-receiving proximity to at least one linked donor fluorphore. A particular configuration of pendant groups can be determined and controlled by the arrangement of the repeat units of the underlying polymeric backbone (also referred to herein as "modular scaffold") to which the pendant groups are attached. The tandem dyes can include a plurality of water solubilizing groups attached to the scaffold and/or the pendant groups at any convenient locations to provide a water soluble polymeric dye. The polymeric backbone, i.e., modular scaffold, can be composed of repeat units which form a polymeric backbone having sidechain groups to which the pendant groups can be attached. The repeat units can be arranged in a variety of configurations to provide for a tandem dye having desirable spectroscopic properties. The distances and arrangement between sites for covalent attachment of the pendant donor fluorophores and the acceptor fluorophore(s) (when present) can be controlled to provide for desirable energy transfer processes. As mentioned above, where desired, the peptidic scaffold and/or pendant fluorophores (i.e., donor and acceptor fluorophores) may include one or more water solubilizing groups (WSG). In some cases, the WSGs are pendant groups connected directly to the backbone, e.g., as sidechains of amino acid residues of a peptidic backbone. In certain cases, the WSGs are substituent groups attached to a pendant donor fluorophore or pendant acceptor fluorophore. In some instances, each of the pendant donor flouorophore groups are substituted with one or more WSG. As used herein, the terms “water solubilizing group” , “water soluble group” and WSG are used interchangeably and refer to a group or substituent that is well solvated in aqueous environments e.g., under physiological conditions, and which imparts improved water solubility upon the molecule to which it is attached. A WSG can increase the solubility of a give polymeric tandem dye in a predominantly aqueous solution, as compared to a control dye which lacks the WSG. The water solubilizing groups may be any convenient hydrophilic group that is well solvated in aqueous environments. A water soluble tandem dye of the present disclosure has solubility under aqueous conditions that makes it especially suitable for application to a variety of biological assays. A variety of water soluble polymer groups can be adapted for use in the WSG of the subject dyes. Any convenient water solubilizing groups (WSG’s) may be included in the dyes described herein to provide for increased water-solubility, e.g., as described above. As summarized above, tandem dyes of embodiments of the invention include a plurality of pendant donor fluorophores and one or more pendant acceptor fluorophores, i.e., a plurality of donor-fluor amino acid acid residues and one or more acceptor-fluor amino acid residues. In some instances, the number of donor fluorophores exceeds the number of acceptor fluorophores. In certain embodiments of the subject tandem dyes, the ratio of donor fluorophores to acceptor fluorophores is selected from 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1, 10:1, and 20:2. In certain cases, the ratio of donor fluorophores to acceptor fluorophores is 2:1. In certain cases, the ratio of donor fluorophores to acceptor fluorophores is 3:1. In certain cases, the ratio of donor fluorophores to acceptor fluorophores is 4:1. In certain cases, the ratio of donor fluorophores to acceptor fluorophores is 5:1. In certain cases, the ratio of donor fluorophores to acceptor fluorophores is 6:1. In certain cases, the ratio of donor fluorophores to acceptor fluorophores is 7:1. In certain cases, the ratio of donor fluorophores to acceptor fluorophores is 8:1. In certain cases, the ratio of donor fluorophores to acceptor fluorophores is 9:1. In certain cases, the ratio of donor fluorophores to acceptor fluorophores is 10:1. As mentioned above, in tandem dyes of the invention, pendant donor and acceptor fluorophores are in energy transfer relationship. As such, in embodiments of the invention, excitation of the donor can lead to energy transfer to, and emission from, the covalently attached acceptor signaling fluorophore(s). Mechanisms for energy transfer between the donor chromophores to a linked acceptor signaling fluorophore include, for example, resonant energy transfer (e.g., Förster (or fluorescence) resonance energy transfer, FRET), quantum charge exchange (Dexter energy transfer) and the like. Under conditions for efficient energy transfer, amplification of the emission from the acceptor fluorophore can occur where the emission from the luminescent acceptor fluorophore is more intense when the incident light (the "pump light") is at a wavelength which is absorbed by, and transferred from, the chromophores of the light harvesting chromophore than when the luminescent acceptor fluorophore is directly excited by the pump light. By “efficient” energy transfer is meant 10% or more, such as 20% or more or 30% or more, 40% or more, 50 % or more, of the energy harvested by the donor chromophores is transferred to the acceptor. By “amplification” is meant that the signal from the acceptor fluorophore is 1.5x or greater when excited by energy transfer from the donor light harvesting chromophore system as compared to direct excitation of the acceptor fluorophore with incident light of an equivalent intensity. The signal may be measured using any convenient method. In some cases, the 1.5x or greater signal refers to an intensity of emitted light. In certain cases, the 1.5x or greater signal refers to an increased signal to noise ratio. In certain embodiments of the tandem dye, the acceptor fluorophore emission is 1.5 fold greater or more when excited by the chromophore as compared to direct excitation of the acceptor fluorophore with incident light, such as 2-fold or greater, 3-fold or greater, 4-fold or greater, 5-fold or greater, 6- fold or greater, 8-fold or greater, 10-fold or greater, 20-fold or greater, 50-fold or greater, 100-fold or greater, or even greater as compared to direct excitation of the acceptor fluorophore with incident light. The tandem dyes of embodiments of the invention may be of any convenient molecular weight (MW). In some cases, the MW of the tandem dye may be expressed as an average molecular weight. In some instances, the tandem dye has an average molecular weight in the range of 2,000 to 200,000 g/mol, such as 5,000 to 100,000 g/mol. As summarized above, tandem dyes of emobdiments of the invention may vary with respect to excitation maximum. As such, tandem dyes of embodiments of the invention may be excited by lasers of a variety of different wavelengths, such as violet, blue, green, yellow, red and ultra-violet lasers. In some instances, tandem dyes of the invention have an excitation maximum that ranges from 340 to 700nm. In some instances, the tandem dye exhibits an effective Stokes shift of 100 nm or more, such as 110nm or more, 120nm or more, 130nm or more, 140nm or more, 150nm or more, 160nm or more, 170nm or more, 180nm or more, 190nm or more, 200nm or more, 250nm or more when the light harvesting chromophore is directly excited with incident light. In some cases, the effective Stokes shift of the tandem dye is up to about 300nm such as 100-300nm, 100-250nm or 100-200nm. The emission of the polymeric tandem dye can have a quantum yield of 0.03 or more, such as a quantum yield of 0.04 or more, 0.05 or more, 0.06 or more, 0.07 or more, 0.08 or more, 0.09 or more, 0.1 or more, 0.15 or more, 0.2 or more, 0.3 or more or even more. In some instances, the polymeric tandem dye has an extinction coefficient of 1 x 10 ⁵ cm ^-1 M ^-1 or more, such as 5 x 10 ⁵ cm ^-1 M ^-1 or more, such as 6 x 10 ⁵ cm ^-1 M ^-1 or more, 7 x 10 ⁵ cm ^-1 M ^-1 or more, 8 x 10 ⁵ cm ^-1 M ^-1 or more, 9 x 10 ⁵ cm ^-1 M ^-1 or more, such as 1 x 10 ⁶ cm ^-1 M ^-1 or more, 1.5 x 10 ⁶ cm ^-1 M ^-1 or more, 2 x 10 ⁶ cm ^-1 M ^-1 or more, 2.5 x 10 ⁶ cm ^-1 M ^-1 or more, 3 x 10 ⁶ cm ^-1 M ^-1 or more, 4 x 10 ⁶ cm ^-1 M ^-1 or more, 5 x 10 ⁶ cm ^-1 M ^-1 or more, 6 x 10 ⁶ cm ^-1 M ^-1 or more, 7 x 10 ⁶ cm ^-1 M ^-1 or more, or 8 x 10 ⁶ cm ^-1 M ^-1 or more. In some embodiments, the polymeric tandem dye has a molar extinction coefficient of 5 x 10 ⁵ M ^-1 cm ^-1 or more. In certain embodiments, the tandem dye has a molar extinction coefficient of 1 x 10 ⁶ M ^-1 cm ^-1 or more. In embodiments, the subject tandem dyes provide for fluorescence emissions from acceptor fluorophores that are brighter than the emissions which are possible from such fluorescent dyes in isolation. The emission of the polymeric tandem dye can have a brightness of 50 mM ^-1 cm ^-1 or more, such as 60 mM ^-1 cm ^-1 or more, 70 mM ^-1 cm ^-1 or more, 80 mM ^-1 cm ^-1 or more, 90 mM ^-1 cm ^-1 or more, 100 mM ^-1 cm ^-1 or more, 150 mM ^-1 cm ^-1 or more, 200 mM ^-1 cm ^-1 or more, 250 mM ^-1 cm ^-1 or more, 300 mM ^-1 cm ^-1 or more, or even more. In certain instances, the emission of the tandem dye has a brightness that is at least 5-fold greater than the brightness of a directly excited acceptor fluorophore, such as at least 10-fold greater, at least 20-fold greater, at least 30-fold greater, at least 50- fold greater, at least 100-fold greater, at least 300-fold greater, or even greater than the brightness of a directly excited acceptor fluorophore. In addition to attributes such as described above, tandem dyes of embodiments of the invention may have one or more additional desirable spectroscopic properties, such as a particular emission maximum wavelength, extinction coefficient, quantum yield, and the like. A variety of emission profiles which depend on a variety of factors such as the selected co-monomers, linking groups, substituents and linked acceptor fluorophores of which the tandem dyes are composed. In some embodiments, the tandem dye has an emission maximum wavelength in the range of 425 to 900 nm, such as in the range of 450nm to 900nm, 475nm to 900 nm, or 500nm to 900nm. In some embodiments, the tandem dyes have a structure described by the formula: wherein: each D is independently a donor fluorophore: A is independently an acceptor fluorophore; B is an internally positioned sensor; R ₁ and R ₃ are each independently selected from terminal group (including but not limited to, alkyl, aryl, hydroxyl, amino, acyl, acyloxy, and amido terminal and/or substituent groups), polymer segment, donor fluorophore, acceptor fluorophore, linker and a linked specific binding member; R ₂ is side chain, such as an amino acid side chain, which may be a side chain found in naturally occurring or synthetic amino acids, as desired; L ₁ , L ₂ and L ₃ are independently linkers, e.g., as defined above, bonded to a D, B or A, respectively, where in some instances these linkers are amino acid side chains, which may be side chains found in naturally occurring or synthetic amino acids, as desired; L ₄ is a non-amino acid spacer; l and n are integers ranging from 1 to 50; m is 1; and o and p are integers ranging from 0 to 100; wherein the formula defines a linear peptidic scaffold of amino acid residues, where residues having donor fluorophores or acceptor fluorophores and non-amino acid spacers, if present, can be positioned at any location in the peptidic scaffold and the amino acid residue having the sensor is present at an internal location of the peptidic scaffold. As such, the above formula does not denote an particular order of the different residues and spacers, apart from the requirement that the amino acid residue to which the sensor is bound is positioned internally in the peptidic scaffold. As mentioned above, L ₄ , when present, is a is a non-amino acid spacer. Examples of non-amino acid spacers of interest include, but are not limited to, those containing a polyalkylene oxide, polyamide alkylene oxide, or derivatives thereof, including polyalkylene oxide and polyamide alkylene oxide comprising an ethylene oxide repeat unit of the formula -(CH ₂ -CH ₂ -O)-. Further examples of polymers of interest include a polyamide having a molecular weight greater than 1,000 Daltons of the formula -[C(O)-X-C(O)-NH-Y-NH]n- or -[NH-Y-NH-C(O)-X-C(O)] _n -, where X and Y are divalent radicals that may be the same or different and may be branched or linear, and n is a discrete integer from 2-100, such as from 2 to 50, and where either or both of X and Y comprises a biocompatible, substantially non-antigenic repeat unit that may be linear or branched. Further examples of repeat units comprise an ethylene oxide of the formula - (CH ₂ -CH ₂ -O)- or -(O-CH ₂ -CH ₂ )- . The number of such spacer repeat units can vary significantly, with the number of such units being from 2 to 500, 2 to 400, 2 to 300, 2 to 200, 2 to 100, 6-100, for example from 2 to 50 or 6 to 50. In some instances, the spacer is a polyethylene glycol. The terms “polyethylene oxide”, “PEO”, "polyethylene glycol” and “PEG” are used interchangeably and refer to a polymeric group including a chain described by the formula --(CH ₂ ----O--) _n - or a derivative thereof. In some embodiments, "n" is 5000 or less, such as 1000 or less, 500 or less, 200 or less, 100 or less, 50 or less, 40 or less, 30 or less, 20 or less, 15 or less, such as 3 to 15, or 10 to 15. It is understood that the PEG polymeric group may be of any convenient length and may include a variety of terminal groups and/or further substituent groups, including but not limited to, alkyl, aryl, hydroxyl, amino, acyl, acyloxy, and amido terminal and/or substituent groups. PEG groups that may be adapted for use in the subject multichromophores include those PEGs described by S. Zalipsky in “Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates”, Bioconjugate Chemistry 1995, 6 (2), 150-165; and by Zhu et al in “Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy”, Chem. Rev., 2012, 112 (8), pp 4687– 4735. Representative tandem dyes according to embodiments of the invention are described by the following structures:

Where A (Acceptor), B (internally positioned sensor, e.g., biomolecule) and D (Donor) are as defined above and B is bound to an internal amino acid residue. METHODS Aspects of the invention include methods of evaluating a sample for the presence of a target analyte. Aspects of the methods include contacting a sample with a tandem dye of the invention having a sensor that specifically binds the target analyte to produce an assay composition comprising the tandem dye contacted sample. The tandem dye employed in embodiments of methods of the invention includes an internally positioned sensor, e.g., as described above. In the following section, the target analyte may be a target molecule of interest or reagent, e.g., primary antibody, bound to the target molecule, depending on whether the tandem dye is employed as a primary or secondary label. Any convenient method may be used to contact the sample with a tandem dye that specifically binds to the target analyte to produce the assay composition. In some instances, the sample is contacted with the tandem dye under conditions in which the tandem dye specifically binds to the target analyte, if present. For specific binding of the tandem dye with the target analyte, an appropriate medium may be used that maintains the biological activity of the components of the sample and sensor of the tandem dye. The medium may be a balanced salt solution, e.g., normal saline, PBS, Hank’s balanced salt solution, etc., conveniently supplemented with fetal calf serum, human platelet lysate or other factors, in conjunction with an acceptable buffer at low concentration, such as from 5-25 mM. Convenient buffers include HEPES, phosphate buffers, lactate buffers, etc. Various media are commercially available and may be used according to the nature of the target analyte, including dMEM, HBSS, dPBS, RPMI, Iscove’s medium, etc., in some cases supplemented with fetal calf serum or human platelet lysate. The final components of the medium, which may be a solution, may be selected depending on the components of the sample which are included. The temperature at which specific binding of the labeled specific binding member to the target analyte takes place may vary, and in some instances may range from 5 ^o C to 50 ^o C, such as from 10 ^o C to 40 ^o C, 15 ^o C to 40 ^o C, 20 ^o C to 40 ^o C, e.g., 20 ^o C, 25 ^o C, 30 ^o C, 35 ^o C or 37 ^o C (e.g., as described above). In some instances, the temperature at which specific binding takes place is selected to be compatible with the biological activity of the sensor, e.g., specific binding member, and/or the target analyte. In certain instances, the temperature is 25 ^o C, 30 ^o C, 35 ^o C or 37 ^o C. In certain cases, the temperature at which specific binding takes place is room temperature (e.g., 25 ^o C), 30 ^o C, 35 ^o C or 37 ^o C. Any convenient incubation time for specific binding may be selected to allow for the formation of a desirable amount of binding complex, and in some instances, may be 1 minute (min) or more, such as 2 min or more, 10 min or more, 30 min or more, 1 hour or more, 2 hours or more, or even 6 hours or more. Any convenient specific binding members may be utilized as sensors in the tandem dyes employed in methods of the invention. Specific binding members of interest include, but are not limited to, those specific binding members that specifically bind cell surface proteins of a variety of cell types, including but not limited to, stem cells, e.g., pluripotent stem cells, hematopoietic stem cells, T cells, T regulator cells, dendritic cells, B Cells, e.g., memory B cells, antigen specific B cells, granulocytes, leukemia cells, lymphoma cells, virus cells (e.g., HIV cells) NK cells, macrophages, monocytes, fibroblasts, epithelial cells, endothelial cells, and erythroid cells. Target cells of interest include cells that have a convenient cell surface marker or antigen that may be captured by a convenient specific binding member conjugate. In some embodiments, the target cell is selected from HIV containing cell, a Treg cell, an antigen-specific T -cell populations, tumor cells or hematopoetic progenitor cells (CD34+) from whole blood, bone marrow or cord blood. Any convenient cell surface proteins or cell markers may be targeted for specific binding to the conjugates employed in the subject methods. In some embodiments, the target cell includes a cell surface marker selected from a cell receptor and a cell surface antigen. In some cases, the target cell may include a cell surface antigen such as CD11b, CD123, CD14, CD15, CD16, CD19, CD193, CD2, CD25, CD27, CD3, CD335, CD36, CD4, CD43, CD45RO, CD56, CD61, CD7, CD8, CD34, CD1c, CD23, CD304, CD235a, T cell receptor alpha/beta, T cell receptor gamma/delta, CD253, CD95, CD20, CD105, CD117, CD120b, Notch4, Lgr5 (N-Terminal), SSEA-3, TRA-1-60 Antigen, Disialoganglioside GD2 and CD71. Any convenient targets may be selected for evaluation utilizing the subject methods. Targets of interest include, but are not limited to, a nucleic acid, such as an RNA, DNA, PNA, CNA, HNA, LNA or ANA molecule, a protein, such as a fusion protein, a modified protein, such as a phosphorylated, glycosylated, ubiquitinated, SUMOylated, or acetylated protein, or an antibody, a peptide, an aggregated biomolecule, a cell, a small molecule, a vitamin and a drug molecule. As used herein, the term “a target protein” refers to all members of the target family, and fragments thereof. The target protein may be any protein of interest, such as a therapeutic or diagnostic target, including but not limited to: hormones, growth factors, transcription factor, receptors, enzymes, cytokines, osteo-inductive factors, colony stimulating factors and immunoglobulins. The term “target protein” is intended to include recombinant and synthetic molecules, which can be prepared using any convenient recombinant expression methods or using any convenient synthetic methods, or purchased commercially. In some embodiments, the polymeric dye conjugates include an antibody or antibody fragment. Any convenient target analyte that specifically binds an antibody or antibody fragment of interest may be targeted in the subject methods. In some embodiments, the target analyte is associated with a cell. In certain instances, the target analyte is a cell surface marker of the cell. In certain cases, the cell surface marker is selected from the group consisting of a cell receptor and a cell surface antigen. In some instances, the target analyte is an intracellular target, and the method further includes treating the cell so as to provide access of the labeled specific binding memberto the intracellular target, e.g., by permeabilizing or lysing the cell. As such, a tandem dye employed in methods of the invention may target a cell surface or intracellular antigen. Alternatively, a sensor of a tandem dye employed in methods of the invention may target a primary antibody that in turn specifically binds to a target cell surface or intracellular antigen. In some embodiments, the sample may include a heterogeneous cell population from which target cells are isolated. In some instances, the sample includes peripheral whole blood, peripheral whole blood in which erythrocytes have been lysed prior to cell isolation, cord blood, bone marrow, density gradient-purified peripheral blood mononuclear cells or homogenized tissue. In some cases, the sample includes hematopoetic progenitor cells (e.g., CD34+ cells) in whole blood, bone marrow or cord blood. In certain embodiments, the sample includes tumor cells in peripheral blood. In certain instances, the sample is a sample including (or suspected of including) viral cells (e.g., HIV). The tandem dyes having internally positioned sensors find use in the subject methods, e.g., for labeling a target cell, particle, target or analyte with a tandem fluorescent dye. For example, tandem dyes of the invention find use in labeling cells to be processed (e.g., detected, analyzed, and/or sorted) in a flow cytometer. The tandem dyes may include specific binding members, e.g., antibodies or binding fragments thereof, that specifically bind to, e.g., cell surface proteins of a variety of cell types (e.g., as described herein). The tandem dyes may be used to investigate a variety of biological (e.g., cellular) properties or processes such as cell cycle, cell proliferation, cell differentiation, DNA repair, T cell signaling, apoptosis, cell surface protein expression and/or presentation, and so forth. Tandem dyes may be used in any application that includes (or may include) antibody-mediated labeling of a cell, particle or analyte. Aspects of the methods include assaying the assay composition, i.e., tandem dye contacted sample, for the presence of a tandem dye-target analyte binding complex to evaluate whether the target analyte is present in the sample. Once the sample has been contacted with the tandem dye, any convenient method may be utilized in assaying the assay composition that is produced for the presence of a tandem dye-target analyte binding complex. The tandem dye-target analyte binding complex is the binding complex that is produced upon specific binding of the sensor of the tandem dye to the target analyte (or primary binding member, e.g., primary antibody, to the target antigent depending on the embodiment), if present. Assaying the assay composition may include detecting a fluorescent signal from the binding complex, if present. In some cases, the assaying includes a separating step where the target analyte, if present, is separated from the sample. A variety of methods can be utilized to separate a target analyte from a sample, e.g., via immobilization on a support. Assay methods of interest include, but are not limited to, any convenient methods and assay formats where pairs of specific binding members find use, are of interest. Methods and assay formats of interest that may be adapted for use with the subject compositions include, but are not limited to, flow cytometry methods, in-situ hybridization methods, enzyme-linked immunosorbent assays (ELISAs), western blot analysis, magnetic cell separation assays and fluorochrome purification chromatography. In certain embodiments, the method further includes contacting the sample with a second specific binding member that specifically binds the target analyte. In certain instances, the second specific binding member is support bound. Any convenient supports may be utilized to immobilize a component of the subject methods (e.g., a second specific binding member). In certain instances, the support is a particle, such as a magnetic particle. In some instances, the second specific binding member and the polymeric dye conjugate produce a sandwich complex that may be isolated and detected, if present, using any convenient methods. In some embodiments, the method further includes flow cytometrically analyzing the polymeric dye conjugate-target analyte binding complex, i.e., a fluorescently labelled target analyte. Assaying for the presence of a labeled specific binding member -target analyte binding complex may provide assay results (e.g., qualitative or quantitative assay data) which can be used to evaluate whether the target analyte is present in the sample. Any convenient supports may be utilized in the subject methods to immobilize any convenient component of the methods, e.g., labelled specific binding member, target, secondary specific binding member, etc. Supports of interest include, but are not limited to: solid substrates, where the substrate can have a variety of configurations, e.g., a sheet, bead, or other structure, such as a plate with wells; beads, polymers, particle, a fibrous mesh, hydrogels, porous matrix, a pin, a microarray surface, a chromatography support, and the like. In some instances, the support is selected from the group consisting of a particle, a planar solid substrate, a fibrous mesh, a hydrogel, a porous matrix, a pin, a microarray surface and a chromatography support. The support may be incorporated into a system that it provides for cell isolation assisted by any convenient methods, such as a manually-operated syringe, a centrifuge or an automated liquid handling system. In some cases, the support finds use in an automated liquid handling system for the high throughput isolation of cells, such as a flow cytometer. In some embodiments of the method, the separating step includes applying an external magnetic field to immobilize a magnetic particle. Any convenient magnet may be used as a source of the external magnetic field (e.g., magnetic field gradient). In some cases, the external magnetic field is generated by a magnetic source, e.g. by a permanent magnet or electromagnet. In some cases, immobilizing the magnetic particles means the magnetic particles accumulate near the surface closest to the magnetic field gradient source, i.e. the magnet. The separating may further include one or more optional washing steps to remove unbound material of the sample from the support. Any convenient washing methods may be used, e.g., washing the immobilized support with a biocompatible buffer which preserves the specific binding interaction of the polymeric dye and the specific binding member. Separation and optional washing of unbound material of the sample from the support provides for an enriched population of target cells where undesired cells and material may be removed. In certain embodiments, the method includes detecting the labeled target analyte. Detecting the labeled target analyte may include exciting the tandem dye with one or more lasers and subsequently detecting fluorescence emission from the fluorescent tandem dye using one or more optical detectors. Detection of the labeled target can be performed using any convenient instruments and methods, including but not limited to, flow cytometry, FACS systems, fluorescence microscopy; fluorescence, luminescence, ultraviolet, and/or visible light detection using a plate reader; high performance liquid chromatography (HPLC); and mass spectrometry. When using fluorescently labeled components in the methods and compositions of the present disclosure, it is recognized that different types of fluorescence detection systems can be used to practice the subject methods. In some cases, high throughput screening can be performed, e.g., systems that use 96 well or greater microtiter plates. A variety of methods of performing assays on fluorescent materials can be utilized, such as those methods described in, e.g., Lakowicz, J. R., Principles of Fluorescence Spectroscopy, New York: Plenum Press (1983); Herman, B., Resonance energy transfer microscopy, in: Fluorescence Microscopy of Living Cells in Culture, Part B, Methods in Cell Biology, vol.30, ed. Taylor, D. L. & Wang, Y.-L., San Diego: Academic Press (1989), pp.219- 243; Turro, N.J., Modern Molecular Photochemistry, Menlo Park: Benjamin/Cummings Publishing Col, Inc. (1978), pp.296-361. Fluorescence in a sample can be measured using a fluorimeter. In some cases, excitation radiation, from an excitation source having a first wavelength, passes through excitation optics. The excitation optics cause the excitation radiation to excite the sample. In response, fluorescently labelled targets in the sample emit radiation which has a wavelength that is different from the excitation wavelength. Collection optics then collect the emission from the sample. The device can include a temperature controller to maintain the sample at a specific temperature while it is being scanned. In certain instances, a multi-axis translation stage moves a microtiter plate holding a plurality of samples in order to position different wells to be exposed. The multi-axis translation stage, temperature controller, auto-focusing feature, and electronics associated with imaging and data collection can be managed by an appropriately programmed digital computer. The computer also can transform the data collected during the assay into another format for presentation. In some embodiments, the method of evaluating a sample for the presence of a target analyte further includes detecting fluorescence in a flow cytometer. In some embodiments, the method of evaluating a sample for the presence of a target analyte further includes imaging the labelling composition contacted sample using fluorescence microscopy. Fluorescence microscopy imaging can be used to identify a polymeric dye conjugate-target analyte binding complex in the contacted sample to evaluate whether the target analyte is present. Microscopy methods of interest that find use in the subject methods include laser scanning confocal microscopy. Also provided are methods of producing tandem dyes having internally positioned sensors, e.g., as described herein. In some embodiments, the method includes: producing a precursor peptidic scaffold comprising first, second and third types of amino acid residues having first, second and third orthogonally reactive side chains, respectively; and conjugating donor fluorophores to any first reactive side chains, acceptor fluorophores to any second reactive side chains and a sensor molecule to any third reactive side chains of the precursor peptidic scaffold. Precursor peptidic scaffolds may be synthesized using any convenient protocol, e.g., using conventional peptide synthesis protocols (see e.g., Chanduru et al., "Chemical Methods for Peptide and Protein Production," Molecules (2013)18(4): 4373–4388). The first, second and third orthogonally reactive side chains may vary as desired, and may include chemoselective tags or groups, e.g., as defined above. As such, the first, second and third orthogonally reactive side chains include orthogonally reactive conjugation tags that may be used to covalently link the donor and acceptor dyes and the sensor to the peptidic scaffold. The term “conjugation tag” refers to a group that includes a chemo-selective functional group (e.g., as described herein) that can covalently link with a compatible functional group of a specific binding member, after optional activation and/or deprotection. Any convenient conjugation tags may be utilized in the subject in order to conjugate the fluors and sensor to the peptidic backbone. In some embodiments, the conjugation tag includes a terminal functional group selected from an amino, a carboxylic acid or a derivative thereof, a thiol, a hydroxyl, a hydrazine, a hydrazide, an azide, an alkyne and a protein reactive group (e.g., amino-reactive, thiol-reactive, hydroxyl-reactive, imidazolyl-reactive or guanidinyl-reactive). Any convenient methods and reagents may be adapted for use in the subject methods in order to covalently link the conjugation tag to the specific binding member. Methods of interest for labeling a target, include but are not limited to, those methods and reagents described by Hermanson, Bioconjugate Techniques, Third edition, Academic Press, 2013. The contacting step may be performed in an aqueous solution. In some instances, the conjugation tag includes an amino functional group and the target molecule includes an activated ester functional group, such as a NHS ester or sulfo-NHS ester, or vice versa. In certain instances, the conjugation tag includes a maleimide functional group and the target molecule includes a thiol functional group, or vice versa. In certain instances, the conjugation tag includes an alkyne (e.g., a cyclooctyne group) functional group and the target molecule includes an azide functional group, or vice versa, which can be conjugated via Click chemistry. In some cases, the method includes a separating step where the product labeled specific binding member is separated from the reaction mixture, e.g., excess reagents or unlabeled specific binding member. A variety of methods may be utilized to separate a target from a sample, e.g., via immobilization on a support, precipitation, chromatography, and the like. The order in which the donor fluorophore, acceptor fluorophore and sensor are conjugated with their respective side chains to produce the desired tandem dye with internally positioned sensor may vary as desired. For example, the donors may be conjugated first, followed by the acceptor and then the sensor. Alternatively, the acceptor may be conjugated first, following by the donor and sensor. In yet other embodiments, the senor may be conjugated first, following which the donors and acceptor(s) may be conjugated, in any desired order. In those instances where the donor and acceptors are conjugated to the peptidic scaffold prior to conjugation of the sensor, the construct prior to conjugation of the sensor may be referred to as a fluorescently labeled peptidic scaffold. In such instances, the fluorescently labeled peptidic scaffold may include: one or more donor- fluor amino acid residues each conjugated to a pendant donor fluorophore; one or more acceptor-fluor amino acid residues each conjugated to a pendant acceptor fluorophore; and an internal amino acid residue conjugated to a chemoselective group or tage; wherein donor and acceptor fluorophores of the fluorescently labeled molecular entity are in energy transfer relationship. In some instances, the method further includes detecting and/or analyzing the product tandem dye. In some instances, the method further includes fluorescently detecting the labeled specific binding member. Any convenient methods may be utilized to detect and/or analyze the specific binding member in conjunction with the subject methods and compositions. Methods of analyzing a target of interest that find use in the subject methods, include but are not limited to, flow cytometry, fluorescence microscopy, in-situ hybridization, enzyme-linked immunosorbent assays (ELISAs), western blot analysis, magnetic cell separation assays and fluorochrome purification chromatography. Detection methods of interest include but are not limited to fluorescence spectroscopy, fluorescence microscopy, nucleic acid sequencing, fluorescence in-situ hybridization (FISH), protein mass spectroscopy, flow cytometry, and the like. Detection may be achieved directly via the polymeric tandem dye, or indirectly by a secondary detection system. The latter may be based on any one or a combination of several different principles including, but not limited to, antibody labelled anti-species antibody and other forms of immunological or non-immunological bridging and signal amplification systems (e.g., biotin-streptavidin technology, protein-A and protein-G mediated technology, or nucleic acid probe/anti-nucleic acid probes, and the like). Suitable reporter molecules may be those known in the field of immunocytochemistry, molecular biology, light, fluorescence, and electron microscopy, cell immunophenotyping, cell sorting, flow cytometry, cell visualization, detection, enumeration, and/or signal output quantification. More than one antibody of specific and/or non-specific nature might be labelled and used simultaneously or sequentially to enhance target detection, identification, and/or analysis. SYSTEMS Aspects of the invention further include systems for use in practicing the subject methods. A sample analysis system can include sample field of view or a flow channel loaded with a sample and labeled specific binding member of the invention, e.g., as described above. In some embodiments, the system is a flow cytometric system including: a flow cytometer including a flow path; a composition in the flow path, wherein the composition includes: a sample and a labled specific binding member (e.g., as described herein). In some embodiments, the system for analyzing a sample is a fluorescence microscopy system, including: a fluorescence microscope comprising a sample field of view; and a composition disposed in the sample field of view, wherein the composition comprises a sample; and a labelled specific binding member (e.g., as described herein). In certain embodiments of the systems, the composition further includes a second specific binding member that is support bound and specifically binds the target analyte. In some cases, the support includes a magnetic particle. As such, in certain instances, the system may also include a controllable external paramagnetic field configured for application to an assay region of the flow channel. The sample may include a cell. In some instances, the sample is a cell- containing biological sample. In some instances, the sample includes a labelled specific binding member specifically bound to a target cell. In certain instances, the target analyte that is specifically bound by the specific binding member is a cell surface marker of the cell. In certain cases, the cell surface marker is selected from a cell receptor and a cell surface antigen. In certain aspects, the system may also include a light source configured to direct light to an assay region of the flow channel or sample field of view. The system may include a detector configured to receive a signal from an assay region of the flow channel or a sample field of view, wherein the signal is provided by the fluorescent composition. Optionally further, the sample analysis system may include one or more additional detectors and/or light sources for the detection of one or more additional signals. In certain aspects, the system may further include computer-based systems configured to detect the presence of the fluorescent signal. A “computer-based system" refers to the hardware means, software means, and data storage means used to analyze the information of the present invention. The minimum hardware of the computer-based systems of the present invention includes a central processing unit (CPU), input means, output means, and data storage means. A skilled artisan can readily appreciate that any one of the currently available computer-based system are suitable for use in the subject systems. The data storage means may include any manufacture including a recording of the present information as described above, or a memory access means that can access such a manufacture. To "record" data, programming or other information on a computer readable medium refers to a process for storing information, using any such methods as known in the art. Any convenient data storage structure may be chosen, based on the means used to access the stored information. A variety of data processor programs and formats can be used for storage, e.g., word processing text file, database format, etc. A “processor” references any hardware and/or software combination that will perform the functions required of it. For example, any processor herein may be a programmable digital microprocessor such as available in the form of an electronic controller, mainframe, server or personal computer (desktop or portable). Where the processor is programmable, suitable programming can be communicated from a remote location to the processor, or previously saved in a computer program product (such as a portable or fixed computer readable storage medium, whether magnetic, optical or solid state device based). For example, a magnetic medium or optical disk may carry the programming, and can be read by a suitable reader communicating with each processor at its corresponding station. In addition to the sensor device and signal processing module, e.g., as described above, systems of the invention may include a number of additional components, such as data output devices, e.g., monitors and/or speakers, data input devices, e.g., interface ports, keyboards, etc., fluid handling components, power sources, etc. In certain aspects, the system includes a flow cytometer. Suitable flow cytometry systems may include, but are not limited to, those described in Ormerod (ed.), Flow Cytometry: A Practical Approach, Oxford Univ. Press (1997); Jaroszeski et al. (eds.), Flow Cytometry Protocols, Methods in Molecular Biology No.91, Humana Press (1997); Practical Flow Cytometry, 3rd ed., Wiley-Liss (1995); Virgo, et al. (2012) Ann Clin Biochem. Jan;49(pt 1):17-28; Linden, et. al., Semin Throm Hemost.2004 Oct;30(5):502-11; Alison, et al. J Pathol, 2010 Dec; 222(4):335-344; and Herbig, et al. (2007) Crit Rev Ther Drug Carrier Syst.24(3):203-255; the disclosures of which are incorporated herein by reference. In certain instances, flow cytometry systems of interest include BD Biosciences FACSCanto ^TM flow cytometer, BD Biosciences FACSCanto ^TM II flow cytometer, BD Accuri ^TM flow cytometer, BD Accuri ^TM C6 Plus flow cytometer, BD Biosciences FACSCelesta ^TM flow cytometer, BD Biosciences FACSLyric ^TM flow cytometer, BD Biosciences FACSVerse ^TM flow cytometer, BD Biosciences FACSymphony ^TM flow cytometer, BD Biosciences LSRFortessa ^TM flow cytometer, BD Biosciences LSRFortessa ^TM X-20 flow cytometer, BD Biosciences FACSPresto ^TM flow cytometer, BD Biosciences FACSVia ^TM flow cytometer and BD Biosciences FACSCalibur ^TM cell sorter, a BD Biosciences FACSCount ^TM cell sorter, BD Biosciences FACSLyric ^TM cell sorter, BD Biosciences Via ^TM cell sorter, BD Biosciences Influx™ cell sorter, BD Biosciences Jazz™ cell sorter, BD Biosciences Aria™ cell sorter, BD Biosciences FACSAria™ II cell sorter, BD Biosciences FACSAria™ III cell sorter, BD Biosciences FACSAria™ Fusion cell sorter and BD Biosciences FACSMelody™ cell sorter, BD Biosciences FACSymphony ^TM S6 cell sorter or the like. In some embodiments, the subject systems are flow cytometric systems, such those described in U.S. Patent Nos.10,663,476; 10,620,111; 10,613,017; 10,605,713; 10,585,031; 10,578,542; 10,578,469; 10,481,074; 10,302,545; 10,145,793; 10,113,967; 10,006,852; 9,952,076; 9,933,341; 9,726,527; 9,453,789; 9,200,334; 9,097,640; 9,095,494; 9,092,034; 8,975,595; 8,753,573; 8,233,146; 8,140,300; 7,544,326; 7,201,875; 7,129,505; 6,821,740; 6,813,017; 6,809,804; 6,372,506; 5,700,692; 5,643,796; 5,627,040; 5,620,842; 5,602,039; 4,987,086; 4,498,766; the disclosures of which are herein incorporated by reference in their entirety. In certain instances, flow cytometry systems of the invention are configured for imaging particles in a flow stream by fluorescence imaging using radiofrequency tagged emission (FIRE), such as those described in Diebold, et al. Nature Photonics Vol.7(10); 806-810 (2013) as well as described in U.S. Patent Nos.9,423,353; 9,784,661; 9,983,132; 10,006,852; 10,078,045; 10,036,699; 10,222,316; 10,288,546; 10,324,019; 10,408,758; 10,451,538; 10,620,111; and U.S. Patent Publication Nos.2017/0133857; 2017/0328826; 2017/0350803; 2018/0275042; 2019/0376895 and 2019/0376894 the disclosures of which are herein incorporated by reference. Other systems may find use in practicing the subject methods. In certain aspects, the system may be a fluorimeter or microscope loaded with a sample having a fluorescent composition of any of the embodiments discussed herein. The fluorimeter or microscope may include a light source configured to direct light to the assay region of the flow channel or sample field of view. The fluorimeter or microscope may also include a detector configured to receive a signal from an assay region of the flow channel or field of view, wherein the signal is provided by the fluorescent composition. KITS Aspects of the invention further include kits including compositions of the invention, e.g., for use in practicing the subject methods. The compositions of the invention can be included as reagents in kits either as starting materials or provided for use in, for example, the methodologies described above. A kit can include a tandem dye having an internally positioned sensor, e.g., as described above, and a container. Any convenient containers can be utilized, such as tubes, bottles, or wells in a multi-well strip or plate, a box, a bag, an insulated container, and the like. The subject kits can further include one or more components selected from a primer specific binding member for a given target analyte, a support bound specific binding member, a cell, a support, a biocompatible aqueous elution buffer, a control (postive and/or negative), etc., and instructions for use, as desired. A given kit may include reagents suitable for a detection of a single target analyte, or multiple reangest suitable for detection of two or more different target analytes, e.g., where a given kit is configured for multiplex detection applications. In certain embodiments, the kit finds use in evaluating a sample for the presence of a target analyte, such as an intracellular target. As such, in some instances, the kit includes one or more components suitable for permeabilizing or lysing cells. The one or more additional components of the kit may be provided in separate containers (e.g., separate tubes, bottles, or wells in a multi-well strip or plate). In certain aspects, the kit further includes reagents for performing a flow cytometric assay. Reagents of interest include, but are not limited to, buffers for reconstitution and dilution, buffers for contacting a cell sample the chromophore, wash buffers, control cells, control beads, fluorescent beads for flow cytometer calibration and combinations thereof. The kit may also include one or more cell fixing reagents such as paraformaldehyde, glutaraldehyde, methanol, acetone, formalin, or any combinations or buffers thereof. Further, the kit may include a cell permeabilizing reagent, such as methanol, acetone or a detergent (e.g., triton, NP-40, saponin, tween 20, digitonin, leucoperm, or any combinations or buffers thereof. Other protein transport inhibitors, cell fixing reagents and cell permeabilizing reagents familiar to the skilled artisan are within the scope of the subject kits. The compositions of the kit may be provided in a liquid composition, such as any suitable buffer. Alternatively, the compositions of the kit may be provided in a dry composition (e.g., may be lyophilized), and the kit may optionally include one or more buffers for reconstituting the dry composition. In certain aspects, the kit may include aliquots of the compositions provided in separate containers (e.g., separate tubes, bottles, or wells in a multi-well strip or plate). In addition, one or more components may be combined into a single container, e.g., a glass or plastic vial, tube or bottle. In certain instances, the kit may further include a container (e.g., such as a box, a bag, an insulated container, a bottle, tube, etc.) in which all of the components (and their separate containers) are present. The kit may further include packaging that is separate from or attached to the kit container and upon which is printed information about the kit, the components of the and/or instructions for use of the kit. In addition to the above components, the subject kits may further include instructions for practicing the subject methods. These instructions may be present in the subject kits in a variety of forms, one or more of which may be present in the kit. One form in which these instructions may be present is as printed information on a suitable medium or substrate, e.g., a piece or pieces of paper on which the information is printed, in the packaging of the kit, in a package insert, etc. Yet another means would be a computer readable medium, e.g., diskette, CD, DVD, portable flash drive, etc., on which the information has been recorded. Yet another means that may be present is a website address which may be used via the Internet to access the information at a removed site. Any convenient means may be present in the kits. UTILITY The tandem dyes, compositions, methods and systems as described herein may find use in a variety of applications, including diagnostic and research applications, in which the labelling, detection and/or analysis of a target of interest is desirable. Such applications include methodologies such as cytometry, microscopy, immunoassays (e.g. competitive or non-competitive), assessment of a free analyte, assessment of receptor bound ligand, and so forth. The compositions, system and methods described herein may be useful in analysis of any of a number of samples, including but not limited to, biological fluids, cell culture samples, and tissue samples. In certain aspects, the compositions, system and methods described herein may find use in methods where analytes are detected in a sample, if present, using fluorescent labels, such as in fluorescent activated cell sorting or analysis, immunoassays, immunostaining, and the like. In certain instances, the compositions and methods find use in applications where the evaluation of a sample for the presence of a target analyte is of interest. In some cases, the methods and compositions find use in any assay format where the detection and/or analysis of a target from a sample is of interest, including but not limited to, flow cytometry, fluorescence microscopy, in-situ hybridization, enzyme- linked immunosorbent assays (ELISAs), western blot analysis, magnetic cell separation assays and fluorochrome purification chromatography. In certain instances, the methods and compositions find use in any application where the fluorescent labelling of a target molecule is of interest. The subject compositions may be adapted for use in any convenient applications where pairs of specific binding members find use, such as biotin-streptavidin and hapten-anti-hapten antibody. The following examples are offered by way of illustration and not by way of limitation. EXAMPLES The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how to make and use the present invention, and are not intended to limit the scope of what the inventors regard as their invention nor are they intended to represent that the experiments below are all or the only experiments performed. Efforts have been made to ensure accuracy with respect to numbers used (e.g. amounts, temperature, etc.) but some experimental errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, molecular weight is weight average molecular weight, temperature is in degrees Celsius, and pressure is at or near atmospheric. Standard abbreviations may be used, e.g., bp, base pair(s); kb, kilobase(s); pl, picoliter(s); s or sec, second(s); min, minute(s); h or hr, hour(s); aa, amino acid(s); nt, nucleotide(s); and the like. A tandem dye having an internally positioned sensor in accordance with an embodiment of the invention has the following structure: Where D is a donor chromophore, A is an acceptor chromophore capable of accepting energy transfer from the donor, and B is a sensor, such as an antibody or specific binding fragment thereof. The tandem dye is prepared as follows. First, a small peptide is made. For this peptide dye, the sequence Ac-KXKXKXCYXKXKXK-NH ₂ is used.The sequence is prepared a commercial peptide synthesis protocol, where: The lysine amine, the cysteine sulfur, and the alkyne provide orthogonal sites for stepwise bonding of D, A, and B. For example, the donor D, in the activated ester or acid linker form, can be linked to the lysine through amidation chemistry in a separate step. The acceptor A, in the maleimide linker form, can be bonded to the cysteine in a separate step. The alkyne group can react with an azide functional group appended to an antibody. D can be a water-soluble BODIPY dye and A can be DY-594 or other suitable acceptor. B can be an antibody or other suitable specific binding member. Notwithstanding the appended claims, the disclosure is also defined by the following clauses: 1. A tandem dye having an internally positioned sensor, the dye comprising: a peptidic scaffold comprising: one or more donor-fluor amino acid residues each conjugated to a pendant donor fluorophore; one or more acceptor-fluor amino acid residues each conjugated to a pendant acceptor fluorophore; and an internal amino acid residue conjugated to a pendant sensor; wherein donor and acceptor fluorophores of the fluorescently labeled molecular entity are in energy transfer relationship. 2. The tandem dye according to Clause 1, wherein the peptidic scaffold comprises more donor-fluor amino acid residues than acceptor-fluor amino acid residues. 3. The tandem dye according to Clause 2, wherein the peptidic scaffold comprises a single acceptor-fluor amino acid residue. 4. The tandem dye according to any of the preceding clauses, wherein the number of donor-fluor amino acid residues ranges from 1 to 50. 5. The tandem dye according to any of the preceding clauses, wherein the peptidic scaffold comprises a number of amino acid residues ranging from 2 to 1,000. 6. The tandem dye according to any of the preceding clauses, wherein the peptidic scaffold further comprises a non-amino acid spacer. 7. The tandem dye according to Clause 6, wherein the non-amino acid spacer separates two amino acid residues of the peptidic scaffold. 8. The tandem dye according to any of Clauses 6 to 7, wherein the non-amino acid spacer comprises a polyalkylene glycol. 9. The tandem dye according to Clause 8, wherein the polyalkylene glycol comprises a polyethylene glycol. 10. The tandem dye according to any of the preceding clauses, wherein the sensor is a specific binding member. 11. The tandem dye according to Clause 10, wherein the specific binding member is selected from the group consisting of carbohydrates, lipids, nucleic acids, polypeptides and peptoids. 12. The tandem dye according to Clause 11, wherein the specific binding member is a polypeptide. 13. The tandem dye according to Clause 12, wherein the specific binding member is an antibody or binding fragment thereof. 14. The tandem dye according to any of the preceding clauses, wherein the donor fluorophore is selected from the group consisting of a fused tricyclic aryl group, a heteroaryl group and a BODIPY group. 15. The tandem dye according to Clause 14, wherein the donor fluorophore is bonded to a water-solubilizing group. 16. The tandem dye according to any of the preceding clauses, wherein the acceptor fluorophore is selected from the group consisting of a cyanine dye, a rhodamine dye, a xanthene dye, a coumarin dye, a polymethine, a pyrene, a dipyrromethene borondifluoride, a napthalimide, a thiazine dye and an acridine dye. 17. The tandem dye according to Clause 16, wherein the acceptor fluorophore is bonded to a water-solubilizing group. 18. A tandem dye having the formula: wherein: D is a donor fluorophore; A is an acceptor fluorophore; B is a sensor; R ₁ and R ₃ are each independently selected from a terminal group, a polymer segment, a donor fluorophore, an acceptor fluorophore, a linker and a linked specific binding member; R ₂ is an amino acid side chain; L ₁ , L ₂ and L ₃ are amino acid side chains bonded to a D, B or A, respectively; L ₄ is a non-amino acid spacer; l and n are integers ranging from 1 to 50; m is 1; and o and p are integers ranging from 0 to 100; wherein the formula defines a linear peptidic scaffold of amino acid residues, where residues having donor fluorophores or acceptor fluorophores and non-amino acid spacers, if present, can be positioned at any location in the peptidic scaffold and the amino acid residue having the sensor is present at an internal location of the peptidic scaffold. 19. The tandem dye according to Clause 18, wherein l is greater than n. 20. The tandem dye according to any of Clauses 18 to 19, wherein p is 0. 21. The tandem dye according to any of Clauses 18 to 19, wherein p is an integer greater than zero. 22. The tandem dye according to Clause 21, wherein the peptidic scaffold comprises an L ₄ separating two amino acid residues. 23. The tandem dye according to any of Clauses 21 to 22, wherein L ₄ comprises a polyalkylene glycol. 24. The tandem dye according to Clause 23, wherein L ₄ comprises a polyethylene glycol. 25. The tandem dye according to any of Clauses 18 to 24, wherein R ₁ comprises an acyl group. 26. The tandem dye according to any of Clauses 18 to 25, wherein R ₃ comprises an amine group. 27. The tandem dye according to any of Clauses 18 to 26, wherein the sensor is selected from the group consisting of carbohydrates, lipids, nucleic acids, polypeptides and peptoids. 28. The tandem dye according to Clause 27, wherein the sensor is a specific binding member. 29. The tandem dye according to Clause 28, wherein the sensor is an antibody. 30. The tandem dye according to Clause 28, wherein the sensor is an antibody binding fragment. 31. The tandem dye according to any of Clauses 18 to 30, wherein D is a fused tricyclic aryl group. 32. The tandem dye according to any of Clauses 18 to 30, wherein D is a heteroaryl group. 33. The tandem dye according to any of Clauses 18 to 30, wherein D is a BODIPY group. 34. The tandem dye according to any of Clauses 31-33, wherein D is bonded to a water-solubilizing group. 35. The tandem dye according to any of Clauses 18 to 34, wherein A is selected from the group consisting of a cyanine dye, a rhodamine dye, a xanthene dye, a coumarin dye, a polymethine, a pyrene, a dipyrromethene borondifluoride, a napthalimide, a thiazine dye and an acridine dye. 36. The tandem dye according to Clause 35, wherein A is bonded to a water- solubilizing group. 37. A method of evaluating a sample for presence of a target analyte, the method comprising: (a) contacting the sample with a tandem dye that specifically binds the target analyte to produce a labeled sample, wherein the tandem dye comprises a peptidic scaffold comprising: (i) one or more donor-fluor amino acid residues each conjugated to a pendant donor fluorophore; (ii) one or more acceptor-fluor amino acid residues each conjugated to a pendant acceptor fluorophore; and (iii) an internal amino acid residue conjugated to the specific binding member; wherein donor and acceptor fluorophores of the fluorescently labeled specific binding member are in energy transfer relationship; and (b) assaying the labeled composition for the presence of a tandem dye-target analyte binding complex to evaluate whether the target analyte is present in the sample. 38. The method according to Clause 37, wherein the peptidic scaffold comprises more donor-fluor amino acid residues than acceptor-fluor amino acid residues. 39. The method according to Clause 38, wherein the peptidic scaffold comprises a single acceptor-fluor amino acid residue. 40. The method according to any of Clauses 37 to 39, wherein the number of donor- fluor amino acid residues ranges from 1 to 50. 41. The method according to any of Clauses 37 to 40, wherein the peptidic scaffold comprises a number of amino acid residues ranging from 2 to 1,000. 42. The method according to any of Clauses 37 to 41, wherein the peptidic scaffold further comprises a non-amino acid spacer. 43. The method according to Clause 42, wherein the non-amino acid spacer separates two amino acid residues of the peptidic scaffold. 44. The method according to any of Clauses 42 to 43, wherein the non-amino acid spacer comprises a polyalkylene glycol. 45. The method according to Clause 8, wherein the polyalkylene glycol comprises a polyethylene glycol. 46. The method according to any of Clauses 37 to 45, wherein the specific binding member is selected from the group consisting of carbohydrates, lipids, nucleic acids, polypeptides and peptoids. 47. The method according to Clause 46, wherein the specific binding member is an antibody or binding fragment thereof. 48. The method according to any of Clauses 37 to 47, wherein the donor fluorophore is selected from the group consisting of a fused tricyclic aryl group, a heteroaryl group and a BODIPY group. 49. The method according to Clause 48, wherein the donor fluorophore is bonded to a water-solubilizing group. 50. The method according to any of Clauses 37 to 49, wherein the acceptor fluorophore is selected from the group consisting of a cyanine dye, a rhodamine dye, a xanthene dye, a coumarin dye, a polymethine, a pyrene, a dipyrromethene borondifluoride, a napthalimide, a thiazine dye and an acridine dye. 51. The method according to Clause 50, wherein the acceptor fluorophore is bonded to a water-solubilizing group. 52. The method according to any of Clauses 37 to 51, further comprising contacting the sample with a second specific binding member that is support bound and specifically binds the target analyte. 53. The method according to Clause 52, wherein the support comprises a magnetic particle. 54. The method according to any of Clauses 37 to 53, wherein the target analyte is associated with a cell. 55. The method according to Clause 54, wherein the target analyte is a cell surface marker of the cell. 56. The method of according to Clause 55, wherein the cell surface marker is selected from the group consisting of a cell receptor and a cell surface antigen. 57. The method according to any of Clauses 37 to 56, wherein the target analyte is an intracellular target. 58. The method according to Clause 57, wherein the method further comprises permeabilizing or lysing the cell. 59. The method according to any of Clauses 37 to 58, wherein the assaying flow cytometrically analyzing the labeled sample. 60. A method of synthesizing a fluorescently labeled molecular entity, the method comprising: producing a precursor peptidic scaffold comprising first, second and third types of amino acid residues having first, second and third orthogonally reactive side chains, respectively; and conjugating donor fluorophores to any first reactive side chains, acceptor fluorophores to any second reactive side chains and a sensor entity to any third reactive side chains of the precursor peptidic scaffold; to produce the fluorescently labeled molecular entity. 61. The method according to Clause 60, wherein the sensor entity is a specific binding member. 62. The method according to Clause 61, wherein the specific binding member is selected from the group consisting of carbohydrates, lipids, nucleic acids, polypeptides and peptoids. 63. The method according to any of Clauses 60 to 62, wherein the donor fluorophore is selected from the group consisting of a fused tricyclic aryl group, a heteroaryl group and a BODIPY group. 64. The method according to any of Clauses 60 to 63, wherein the acceptor fluorophore is selected from the group consisting of a cyanine dye, a rhodamine dye, a xanthene dye, a coumarin dye, a polymethine, a pyrene, a dipyrromethene borondifluoride, a napthalimide, a thiazine dye and an acridine dye. 65. A fluorescently labeled peptidic scaffold comprising: one or more donor-fluor amino acid residues each conjugated to a pendant donor fluorophore; one or more acceptor-fluor amino acid residues each conjugated to a pendant acceptor fluorophore; and an internal amino acid residue conjugated to a chemoselective group; wherein donor and acceptor fluorophores of the fluorescently labeled molecular entity are in energy transfer relationship. 66. The fluorescently labeled peptidic scaffold according to Clause 65, wherein the peptidic scaffold comprises more donor-fluor amino acid residues than acceptor-fluor amino acid residues. 67. The fluorescently labeled peptidic scaffold according to Clause 66, wherein the peptidic scaffold comprises a single acceptor-fluor amino acid residue. 68. The fluorescently labeled peptidic scaffold according to any of Clauses 65 to 67, wherein the number of donor-fluor amino acid residues ranges from 1 to 50. 69. The fluorescently labeled peptidic scaffold according to any of Clauses 65 to 68, wherein the peptidic scaffold comprises a number of amino acid residues ranging from 2 to 1,000. 70. The fluorescently labeled peptidic scaffold according to any of Clauses 65 to 69, wherein the peptidic scaffold further comprises a non-amino acid spacer. 71. The fluorescently labeled peptidic scaffold according to Clause 70, wherein the non-amino acid spacer separates two amino acid residues of the peptidic scaffold. 72. The fluorescently labeled peptidic scaffold according to any of Clauses 70 to 71, wherein the non-amino acid spacer comprises a polyalkylene glycol. 73. The fluorescently labeled peptidic scaffold according to Clause 72, wherein the polyalkylene glycol comprises a polyethylene glycol. 74. The fluorescently labeled peptidic scaffold according to any of Clauses 65 to 73, wherein the donor fluorophore is selected from the group consisting of a fused tricyclic aryl group, a heteroaryl group and a BODIPY group. 75. The fluorescently labeled peptidic scaffold according to Clause 74, wherein the donor fluorophore is bonded to a water-solubilizing group. 76. The fluorescently labeled peptidic scaffold according to any of Clauses 65 to 75, wherein the acceptor fluorophore is selected from the group consisting of a cyanine dye, a rhodamine dye, a xanthene dye, a coumarin dye, a polymethine, a pyrene, a dipyrromethene borondifluoride, a napthalimide, a thiazine dye and an acridine dye. 77. The fluorescently labeled peptidic scaffold according to Clause 76, wherein the acceptor fluorophore is bonded to a water-solubilizing group. 78. A kit comprising: a peptidic scaffold comprising: one or more donor-fluor amino acid residues each conjugated to a pendant donor fluorophore; one or more acceptor-fluor amino acid residues each conjugated to a pendant acceptor fluorophore; and an internal amino acid residue comprising a chemoselective group or a conjugated specific binding member; wherein donor and acceptor fluorophores of the fluorescently labeled molecular entity are in energy transfer relationship. 79. The kit according to Clause 78, wherein the peptidic scaffold comprises more donor-fluor amino acid residues than acceptor-fluor amino acid residues. 80. The kit according to Clause 79, wherein the peptidic scaffold comprises a single acceptor-fluor amino acid residue. 81. The kit according to any of Clauses 78 to 80, wherein the number of donor-fluor amino acid residues ranges from 1 to 50. 82. The kit according to any of Clauses 78 to 81, wherein the peptidic scaffold comprises a number of amino acid residues ranging from 2 to 1,000. 83. The kit according to any of Clauses 78 to 82, wherein the peptidic scaffold further comprises a non-amino acid spacer. 84. The kit according to Clause 83, wherein the non-amino acid spacer separates two amino acid residues of the peptidic scaffold. 85. The kit according to any of Clauses 83 to 84, wherein the non-amino acid spacer comprises a polyalkylene glycol. 86. The kit according to Clause 85, wherein the polyalkylene glycol comprises a polyethylene glycol. 87. The kit according to any of Clauses 78 to 86, wherein the internal amino acid residue comprises a chemoselective group. 88. The kit according to any of Clauses 78 to 86, wherein the internal amino acid residue comprises a specific binding member. 89. The kit according to Clause 88, wherein the specific binding member is an antibody or binding fragment thereof. 90. The kit according to any of Clauses 78 to 89, wherein the donor fluorophore is selected from the group consisting of a fused tricyclic aryl group, a heteroaryl group and a BODIPY group. 91. The kit according to Clause 90, wherein the donor fluorophore is bonded to a water-solubilizing group. 92. The kit according to any of Clauses 78 to 91, wherein the acceptor fluorophore is selected from the group consisting of a cyanine dye, a rhodamine dye, a xanthene dye, a coumarin dye, a polymethine, a pyrene, a dipyrromethene borondifluoride, a napthalimide, a thiazine dye and an acridine dye. 93. The kit according to Clause 92, wherein the acceptor fluorophore is bonded to a water-solubilizing group. 94. The kit according to any of Clauses 78 to 93, wherein the kit further comprises a second fluorescently labeled specific binding member. In at least some of the previously described embodiments, one or more elements used in an embodiment can interchangeably be used in another embodiment unless such a replacement is not technically feasible. It will be appreciated by those skilled in the art that various other omissions, additions and modifications may be made to the methods and structures described above without departing from the scope of the claimed subject matter. All such modifications and changes are intended to fall within the scope of the subject matter, as defined by the appended claims. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “ a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “ a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that virtually any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.” In addition, where features or aspects of the disclosure are described in terms of Markush groups, those skilled in the art will recognize that the disclosure is also thereby described in terms of any individual member or subgroup of members of the Markush group. As will be understood by one skilled in the art, for any and all purposes, such as in terms of providing a written description, all ranges disclosed herein also encompass any and all possible sub-ranges and combinations of sub-ranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, tenths, etc. As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, etc. As will also be understood by one skilled in the art all language such as “up to,” “at least,” “greater than,” “less than,” and the like include the number recited and refer to ranges which can be subsequently broken down into sub-ranges as discussed above. Finally, as will be understood by one skilled in the art, a range includes each individual member. Thus, for example, a group having 1-3 articles refers to groups having 1, 2, or 3 articles. Similarly, a group having 1-5 articles refers to groups having 1, 2, 3, 4, or 5 articles, and so forth. Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims. Accordingly, the preceding merely illustrates the principles of the invention. It will be appreciated that those skilled in the art will be able to devise various arrangements which, although not explicitly described or shown herein, embody the principles of the invention and are included within its spirit and scope. Furthermore, all examples and conditional language recited herein are principally intended to aid the reader in understanding the principles of the invention and the concepts contributed by the inventors to furthering the art, and are to be construed as being without limitation to such specifically recited examples and conditions. Moreover, all statements herein reciting principles, aspects, and embodiments of the invention as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, it is intended that such equivalents include both currently known equivalents and equivalents developed in the future, i.e., any elements developed that perform the same function, regardless of structure. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the claims. The scope of the present invention, therefore, is not intended to be limited to the exemplary embodiments shown and described herein. Rather, the scope and spirit of present invention is embodied by the appended claims. In the claims, 35 U.S.C. §112(f) or 35 U.S.C. §112(6) is expressly defined as being invoked for a limitation in the claim only when the exact phrase "means for" or the exact phrase "step for" is recited at the beginning of such limitation in the claim; if such exact phrase is not used in a limitation in the claim, then 35 U.S.C. § 112 (f) or 35 U.S.C. §112(6) is not invoked.